##fileformat=VCFv4.2
##FILTER=<ID=PASS,Description="All filters passed">
##FILTER=<ID=FS,Description="FS > 30.0">
##FILTER=<ID=LowQual,Description="Low quality">
##FILTER=<ID=QD,Description="QD < 2.0">
##FILTER=<ID=SnpCluster,Description="SNPs found in clusters">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Allelic depths for the ref and alt alleles in the order listed">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Approximate read depth (reads with MQ=255 or with bad mates are filtered)">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=PL,Number=G,Type=Integer,Description="Normalized, Phred-scaled likelihoods for genotypes as defined in the VCF specification">
##GATKCommandLine=<ID=HaplotypeCaller,CommandLine="HaplotypeCaller  --standard-min-confidence-threshold-for-calling 20.0 --recover-dangling-heads true --dont-use-soft-clipped-bases true --output /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling/work_dir/chr1.interval.vcf --intervals /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling/work_dir/chr1.intervals --input /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling/work_dir/recalibrated.bam --reference /seq/RNASEQ/__ctat_genome_lib_building/GRCh37_gencode_v19_CTAT_lib_Mar272019.plug-n-play/ctat_genome_lib_build_dir/ref_genome.fa  --use-new-qual-calculator true --use-old-qual-calculator false --annotate-with-num-discovered-alleles false --heterozygosity 0.001 --indel-heterozygosity 1.25E-4 --heterozygosity-stdev 0.01 --max-alternate-alleles 6 --max-genotype-count 1024 --sample-ploidy 2 --num-reference-samples-if-no-call 0 --genotyping-mode DISCOVERY --genotype-filtered-alleles false --contamination-fraction-to-filter 0.0 --output-mode EMIT_VARIANTS_ONLY --all-site-pls false --gvcf-gq-bands 1 --gvcf-gq-bands 2 --gvcf-gq-bands 3 --gvcf-gq-bands 4 --gvcf-gq-bands 5 --gvcf-gq-bands 6 --gvcf-gq-bands 7 --gvcf-gq-bands 8 --gvcf-gq-bands 9 --gvcf-gq-bands 10 --gvcf-gq-bands 11 --gvcf-gq-bands 12 --gvcf-gq-bands 13 --gvcf-gq-bands 14 --gvcf-gq-bands 15 --gvcf-gq-bands 16 --gvcf-gq-bands 17 --gvcf-gq-bands 18 --gvcf-gq-bands 19 --gvcf-gq-bands 20 --gvcf-gq-bands 21 --gvcf-gq-bands 22 --gvcf-gq-bands 23 --gvcf-gq-bands 24 --gvcf-gq-bands 25 --gvcf-gq-bands 26 --gvcf-gq-bands 27 --gvcf-gq-bands 28 --gvcf-gq-bands 29 --gvcf-gq-bands 30 --gvcf-gq-bands 31 --gvcf-gq-bands 32 --gvcf-gq-bands 33 --gvcf-gq-bands 34 --gvcf-gq-bands 35 --gvcf-gq-bands 36 --gvcf-gq-bands 37 --gvcf-gq-bands 38 --gvcf-gq-bands 39 --gvcf-gq-bands 40 --gvcf-gq-bands 41 --gvcf-gq-bands 42 --gvcf-gq-bands 43 --gvcf-gq-bands 44 --gvcf-gq-bands 45 --gvcf-gq-bands 46 --gvcf-gq-bands 47 --gvcf-gq-bands 48 --gvcf-gq-bands 49 --gvcf-gq-bands 50 --gvcf-gq-bands 51 --gvcf-gq-bands 52 --gvcf-gq-bands 53 --gvcf-gq-bands 54 --gvcf-gq-bands 55 --gvcf-gq-bands 56 --gvcf-gq-bands 57 --gvcf-gq-bands 58 --gvcf-gq-bands 59 --gvcf-gq-bands 60 --gvcf-gq-bands 70 --gvcf-gq-bands 80 --gvcf-gq-bands 90 --gvcf-gq-bands 99 --indel-size-to-eliminate-in-ref-model 10 --use-alleles-trigger false --disable-optimizations false --just-determine-active-regions false --dont-genotype false --do-not-run-physical-phasing false --use-filtered-reads-for-annotations false --correct-overlapping-quality false --adaptive-pruning false --do-not-recover-dangling-branches false --consensus false --dont-trim-active-regions false --max-disc-ar-extension 25 --max-gga-ar-extension 300 --padding-around-indels 150 --padding-around-snps 20 --kmer-size 10 --kmer-size 25 --dont-increase-kmer-sizes-for-cycles false --allow-non-unique-kmers-in-ref false --num-pruning-samples 1 --min-dangling-branch-length 4 --recover-all-dangling-branches false --max-num-haplotypes-in-population 128 --min-pruning 2 --adaptive-pruning-initial-error-rate 0.001 --pruning-lod-threshold 2.302585092994046 --max-unpruned-variants 100 --debug-assembly false --debug-graph-transformations false --capture-assembly-failure-bam false --error-correct-reads false --kmer-length-for-read-error-correction 25 --min-observations-for-kmer-to-be-solid 20 --likelihood-calculation-engine PairHMM --base-quality-score-threshold 18 --pair-hmm-gap-continuation-penalty 10 --pair-hmm-implementation FASTEST_AVAILABLE --pcr-indel-model CONSERVATIVE --phred-scaled-global-read-mismapping-rate 45 --native-pair-hmm-threads 4 --native-pair-hmm-use-double-precision false --bam-writer-type CALLED_HAPLOTYPES --min-base-quality-score 10 --smith-waterman JAVA --emit-ref-confidence NONE --max-mnp-distance 0 --min-assembly-region-size 50 --max-assembly-region-size 300 --assembly-region-padding 100 --max-reads-per-alignment-start 50 --active-probability-threshold 0.002 --max-prob-propagation-distance 50 --force-active false --interval-set-rule UNION --interval-padding 0 --interval-exclusion-padding 0 --interval-merging-rule ALL --read-validation-stringency SILENT --seconds-between-progress-updates 10.0 --disable-sequence-dictionary-validation false --create-output-bam-index true --create-output-bam-md5 false --create-output-variant-index true --create-output-variant-md5 false --lenient false --add-output-sam-program-record true --add-output-vcf-command-line true --cloud-prefetch-buffer 40 --cloud-index-prefetch-buffer -1 --disable-bam-index-caching false --sites-only-vcf-output false --help false --version false --showHidden false --verbosity INFO --QUIET false --use-jdk-deflater false --use-jdk-inflater false --gcs-max-retries 20 --gcs-project-for-requester-pays  --disable-tool-default-read-filters false --minimum-mapping-quality 20 --disable-tool-default-annotations false --enable-all-annotations false",Version="4.1.2.0",Date="July 30, 2019 12:27:41 AM UTC">
##GATKCommandLine=<ID=SelectVariants,CommandLine="SelectVariants  --output /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/HaplotypeCaller.hard_cutoff_filters_applied.selected_variants.vcf --exclude-filtered true --select-type-to-include SNP --variant /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/HaplotypeCaller.hard_cutoff_filters_applied.vcf --reference /seq/RNASEQ/__ctat_genome_lib_building/GRCh37_gencode_v19_CTAT_lib_Mar272019.plug-n-play/ctat_genome_lib_build_dir/ref_genome.fa  --invertSelect false --exclude-non-variants false --preserve-alleles false --remove-unused-alternates false --restrict-alleles-to ALL --keep-original-ac false --keep-original-dp false --mendelian-violation false --invert-mendelian-violation false --mendelian-violation-qual-threshold 0.0 --select-random-fraction 0.0 --remove-fraction-genotypes 0.0 --fully-decode false --max-indel-size 2147483647 --min-indel-size 0 --max-filtered-genotypes 2147483647 --min-filtered-genotypes 0 --max-fraction-filtered-genotypes 1.0 --min-fraction-filtered-genotypes 0.0 --max-nocall-number 2147483647 --max-nocall-fraction 1.0 --set-filtered-gt-to-nocall false --allow-nonoverlapping-command-line-samples false --suppress-reference-path false --interval-set-rule UNION --interval-padding 0 --interval-exclusion-padding 0 --interval-merging-rule ALL --read-validation-stringency SILENT --seconds-between-progress-updates 10.0 --disable-sequence-dictionary-validation false --create-output-bam-index true --create-output-bam-md5 false --create-output-variant-index true --create-output-variant-md5 false --lenient false --add-output-sam-program-record true --add-output-vcf-command-line true --cloud-prefetch-buffer 40 --cloud-index-prefetch-buffer -1 --disable-bam-index-caching false --sites-only-vcf-output false --help false --version false --showHidden false --verbosity INFO --QUIET false --use-jdk-deflater false --use-jdk-inflater false --gcs-max-retries 20 --gcs-project-for-requester-pays  --disable-tool-default-read-filters false",Version="4.1.2.0",Date="August 1, 2019 5:02:57 PM EDT">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Allele count in genotypes  for each ALT allele  in the same order as listed">
##INFO=<ID=AF,Number=A,Type=Float,Description="Allele Frequency  for each ALT allele  in the same order as listed">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=BaseQRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt Vs. Ref base qualities">
##INFO=<ID=DP,Number=1,Type=Integer,Description="Approximate read depth; some reads may have been filtered">
##INFO=<ID=DS,Number=0,Type=Flag,Description="Were any of the samples downsampled?">
##INFO=<ID=ExcessHet,Number=1,Type=Float,Description="Phred-scaled p-value for exact test of excess heterozygosity">
##INFO=<ID=FS,Number=1,Type=Float,Description="Phred-scaled p-value using Fisher's exact test to detect strand bias">
##INFO=<ID=InbreedingCoeff,Number=1,Type=Float,Description="Inbreeding coefficient as estimated from the genotype likelihoods per-sample when compared against the Hardy-Weinberg expectation">
##INFO=<ID=MLEAC,Number=A,Type=Integer,Description="Maximum likelihood expectation (MLE) for the allele counts (not necessarily the same as the AC)  for each ALT allele  in the same order as listed">
##INFO=<ID=MLEAF,Number=A,Type=Float,Description="Maximum likelihood expectation (MLE) for the allele frequency (not necessarily the same as the AF)  for each ALT allele  in the same order as listed">
##INFO=<ID=MQ,Number=1,Type=Float,Description="RMS Mapping Quality">
##INFO=<ID=MQRankSum,Number=1,Type=Float,Description="Z-score From Wilcoxon rank sum test of Alt vs. Ref read mapping qualities">
##INFO=<ID=QD,Number=1,Type=Float,Description="Variant Confidence/Quality by Depth">
##INFO=<ID=ReadPosRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt vs. Ref read position bias">
##INFO=<ID=SOR,Number=1,Type=Float,Description="Symmetric Odds Ratio of 2x2 contingency table to detect strand bias">
##contig=<ID=chr1,length=249250621,assembly=ref_genome.fa>
##contig=<ID=chr2,length=243199373,assembly=ref_genome.fa>
##contig=<ID=chr3,length=198022430,assembly=ref_genome.fa>
##contig=<ID=chr4,length=191154276,assembly=ref_genome.fa>
##contig=<ID=chr5,length=180915260,assembly=ref_genome.fa>
##contig=<ID=chr6,length=171115067,assembly=ref_genome.fa>
##contig=<ID=chr7,length=159138663,assembly=ref_genome.fa>
##contig=<ID=chr8,length=146364022,assembly=ref_genome.fa>
##contig=<ID=chr9,length=141213431,assembly=ref_genome.fa>
##contig=<ID=chr10,length=135534747,assembly=ref_genome.fa>
##contig=<ID=chr11,length=135006516,assembly=ref_genome.fa>
##contig=<ID=chr12,length=133851895,assembly=ref_genome.fa>
##contig=<ID=chr13,length=115169878,assembly=ref_genome.fa>
##contig=<ID=chr14,length=107349540,assembly=ref_genome.fa>
##contig=<ID=chr15,length=102531392,assembly=ref_genome.fa>
##contig=<ID=chr16,length=90354753,assembly=ref_genome.fa>
##contig=<ID=chr17,length=81195210,assembly=ref_genome.fa>
##contig=<ID=chr18,length=78077248,assembly=ref_genome.fa>
##contig=<ID=chr19,length=59128983,assembly=ref_genome.fa>
##contig=<ID=chr20,length=63025520,assembly=ref_genome.fa>
##contig=<ID=chr21,length=48129895,assembly=ref_genome.fa>
##contig=<ID=chr22,length=51304566,assembly=ref_genome.fa>
##contig=<ID=chrX,length=155270560,assembly=ref_genome.fa>
##contig=<ID=chrY,length=59373566,assembly=ref_genome.fa>
##contig=<ID=chrM,length=16569,assembly=ref_genome.fa>
##reference=file:///seq/RNASEQ/__ctat_genome_lib_building/GRCh37_gencode_v19_CTAT_lib_Mar272019.plug-n-play/ctat_genome_lib_build_dir/ref_genome.fa
##source=HaplotypeCaller
##source=SelectVariants
##SnpEffVersion="4.1k (build 2015-09-07), by Pablo Cingolani"
##SnpEffCmd="SnpEff  -nostats -noLof -no-downstream -no-upstream hg19 "
##INFO=<ID=ANN,Number=.,Type=String,Description="Functional annotations: 'Allele | Annotation | Annotation_Impact | Gene_Name | Gene_ID | Feature_Type | Feature_ID | Transcript_BioType | Rank | HGVS.c | HGVS.p | cDNA.pos / cDNA.length | CDS.pos / CDS.length | AA.pos / AA.length | Distance | ERRORS / WARNINGS / INFO'">
##INFO=<ID=GENE,Number=.,Type=String,Description="The name of the gene/s in the genomic region of the SNP as annotated by SNPeff">
##INFO=<ID=COMMON,Number=1,Type=Integer,Description="RS is a common SNP.  A common SNP is one that has at least one 1000Genomes population with a minor allele of frequency >= 1% and for which 2 or more founders contribute to that minor allele frequency.">
##INFO=<ID=PM,Number=0,Type=Flag,Description="Variant is Precious(Clinical,Pubmed Cited)">
##INFO=<ID=NSF,Number=0,Type=Flag,Description="Has non-synonymous frameshift A coding region variation where one allele in the set changes all downstream amino acids. FxnClass = 44">
##INFO=<ID=NSM,Number=0,Type=Flag,Description="Has non-synonymous missense A coding region variation where one allele in the set changes protein peptide. FxnClass = 42">
##INFO=<ID=NSN,Number=0,Type=Flag,Description="Has non-synonymous nonsense A coding region variation where one allele in the set changes to STOP codon (TER). FxnClass = 41">
##INFO=<ID=SAO,Number=1,Type=Integer,Description="Variant Allele Origin: 0 - unspecified, 1 - Germline, 2 - Somatic, 3 - Both">
##INFO=<ID=KGPROD,Number=0,Type=Flag,Description="Has 1000 Genome submission">
##INFO=<ID=KGValidated,Number=0,Type=Flag,Description="1000 Genome validated">
##INFO=<ID=MUT,Number=0,Type=Flag,Description="Is mutation (journal citation, explicit fact): a low frequency variation that is cited in journal and other reputable sources">
##INFO=<ID=WTD,Number=0,Type=Flag,Description="Is Withdrawn by submitter If one member ss is withdrawn by submitter, then this bit is set.  If all member ss' are withdrawn, then the rs is deleted to SNPHistory">
##INFO=<ID=VLD,Number=0,Type=Flag,Description="Is Validated.  This bit is set if the variant has 2+ minor allele count based on frequency or genotype data.">
##INFO=<ID=RS,Number=1,Type=Integer,Description="dbSNP ID (i.e. rs number)">
##INFO=<ID=PMC,Number=0,Type=Flag,Description="Links exist to PubMed Central article">
##bcftools_annotateVersion=1.8+htslib-1.8
##bcftools_annotateCommand=annotate --output-type z --annotations /seq/RNASEQ/__ctat_genome_lib_building/GRCh37_gencode_v19_CTAT_lib_Mar272019.plug-n-play/ctat_genome_lib_build_dir/ctat_mutation_lib/dbsnp.vcf.gz --columns INFO/COMMON,INFO/PM,INFO/NSF,INFO/NSM,INFO/NSN,INFO/SAO,INFO/KGPROD,INFO/KGValidated,INFO/MUT,INFO/WTD,INFO/VLD,INFO/RS,INFO/PMC --output /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/variants.init_snpeff_updated_RNAeditAnnot_dbsnp.vcf.gz /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/variants.init_snpeff_updated_RNAeditAnnot.vcf.gz; Date=Thu Aug  8 16:25:08 2019
##INFO=<ID=COSMIC_ID,Type=String,Description="COSMIC mutation id (unique).">
##INFO=<ID=TISSUE,Type=String,Description="The primary tissue/cancer and subtype from which the sample originated.">
##INFO=<ID=TUMOR,Type=String,Description="The histological classification of the sample.">
##INFO=<ID=FATHMM,Type=String,Description="FATHMM (Functional Analysis through Hidden Markov Models). 'Pathogenic'=Cancer or damaging, 'Neutral'=Passanger or Tolerated.">
##INFO=<ID=SOMATIC,Type=String,Description="Information on whether the sample was reported to be Confirmed Somatic. 'Confirmed somatic'=if the mutation has been confimed to be somatic in the experiment by sequencing both the tumour and a matched normal from the same patient, 'Previously Observed'=when the mutation has been reported as somatic previously but not in current paper, 'variant of unknown origin'=when the mutation is known to be somatic but the tumour was sequenced without a matched normal">
##bcftools_annotateCommand=annotate --output-type z --annotations /seq/RNASEQ/__ctat_genome_lib_building/GRCh37_gencode_v19_CTAT_lib_Mar272019.plug-n-play/ctat_genome_lib_build_dir/ctat_mutation_lib/cosmic.vcf.gz --columns INFO/COSMIC_ID,INFO/TISSUE,INFO/TUMOR,INFO/FATHMM,INFO/SOMATIC --output /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/variants.init_snpeff_updated_RNAeditAnnot_dbsnp_cosmic_annotated.vcf.gz /seq/RNASEQ/mbrown/CTAT/Mutations/HaploidCaller/HG19/GIAB_varcalling_test/work_dir/variants.init_snpeff_updated_RNAeditAnnot_dbsnp.vcf.gz; Date=Thu Aug  8 16:27:57 2019
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	SRR5665260_1_fq
chr18	691266	.	A	G	616.6	PASS	GENE=ENOSF1;AC=1;AF=0.5;AN=2;BaseQRankSum=0.582;DP=33;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.68;ReadPosRankSum=1.86;SOR=0.527;ANN=G|missense_variant|MODERATE|ENOSF1|ENOSF1|transcript|NM_202758.3|Coding|6/15|c.497T>C|p.Met166Thr|508/5345|497/1353|166/450||,G|missense_variant|MODERATE|ENOSF1|ENOSF1|transcript|NM_001126123.3|Coding|5/16|c.188T>C|p.Met63Thr|393/4188|188/1086|63/361||,G|missense_variant|MODERATE|ENOSF1|ENOSF1|transcript|NM_017512.5|Coding|6/16|c.434T>C|p.Met145Thr|509/5388|434/1332|145/443||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2612086;COSMIC_ID=COSM3721630;TISSUE=upper_aerodigestive_tract;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:9,24:33:99:624,0,181
chr18	724612	.	A	G	400.02	PASS	GENE=YES1;AC=2;AF=1;AN=2;DP=10;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.29;SOR=2.303;ANN=G|synonymous_variant|LOW|YES1|YES1|transcript|NM_005433.3|Coding|12/12|c.1444T>C|p.Leu482Leu|1665/4685|1444/1632|482/543||;COMMON=1;SAO=0;KGPROD;VLD;RS=537141;COSMIC_ID=COSM6503403;TISSUE=lung;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,10:10:30:414,30,0
chr18	2547500	.	G	T	264.6	PASS	GENE=METTL4;AC=1;AF=0.5;AN=2;BaseQRankSum=0.925;DP=25;ExcessHet=3.0103;FS=3.831;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.58;ReadPosRankSum=-0.361;SOR=1.567;ANN=T|missense_variant|MODERATE|METTL4|METTL4|transcript|NM_022840.3|Coding|6/9|c.928C>A|p.Gln310Lys|1708/3674|928/1419|310/472||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2677879;COSMIC_ID=COSM6354095;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:15,10:25:99:272,0,449
chr18	2616457	.	G	C	755.6	PASS	GENE=NDC80;AC=1;AF=0.5;AN=2;BaseQRankSum=1.418;DP=50;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.11;ReadPosRankSum=0.214;SOR=0.701;ANN=C|missense_variant|MODERATE|NDC80|NDC80|transcript|NM_006101.2|Coding|17/17|c.1813G>C|p.Ala605Pro|1995/2172|1813/1929|605/642||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=9051;COSMIC_ID=COSM3756105;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:27,23:50:99:763,0,869
chr18	2656248	.	G	C	696.03	PASS	GENE=SMCHD1;AC=2;AF=1;AN=2;DP=24;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29;SOR=1.519;ANN=C|synonymous_variant|LOW|SMCHD1|SMCHD1|transcript|NM_015295.2|Coding|1/48|c.174G>C|p.Ala58Ala|363/8672|174/6018|58/2005||;COMMON=1;PM;SAO=0;KGPROD;VLD;RS=2430853;PMC;COSMIC_ID=COSM3756108;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,24:24:71:710,71,0
chr18	2700877	.	A	G	877.6	PASS	GENE=SMCHD1;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.2;DP=64;ExcessHet=3.0103;FS=2.11;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.71;ReadPosRankSum=0.047;SOR=0.446;ANN=G|synonymous_variant|LOW|SMCHD1|SMCHD1|transcript|NM_015295.2|Coding|12/48|c.1608A>G|p.Lys536Lys|1797/8672|1608/6018|536/2005||;COMMON=0;SAO=0;KGPROD;RS=72862973	GT:AD:DP:GQ:PL	0/1:30,34:64:99:885,0,809
chr18	2707619	.	G	A	2027.03	PASS	GENE=SMCHD1;AC=2;AF=1;AN=2;BaseQRankSum=0.31;DP=57;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.47;ReadPosRankSum=1.734;SOR=0.285;ANN=A|missense_variant|MODERATE|SMCHD1|SMCHD1|transcript|NM_015295.2|Coding|16/48|c.2122G>A|p.Val708Ile|2311/8672|2122/6018|708/2005||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2276092;COSMIC_ID=COSM3932818;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,56:57:99:2041,135,0
chr18	2740714	.	A	G	2281.03	PASS	GENE=SMCHD1;AC=2;AF=1;AN=2;DP=73;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.25;SOR=1.257;ANN=G|synonymous_variant|LOW|SMCHD1|SMCHD1|transcript|NM_015295.2|Coding|28/48|c.3528A>G|p.Thr1176Thr|3717/8672|3528/6018|1176/2005||;COMMON=1;SAO=0;KGPROD;VLD;RS=12327477;COSMIC_ID=COSM3756113;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,73:73:99:2295,219,0
chr18	2750477	.	A	G	3317.03	PASS	GENE=SMCHD1;AC=2;AF=1;AN=2;DP=109;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.43;SOR=0.711;ANN=G|synonymous_variant|LOW|SMCHD1|SMCHD1|transcript|NM_015295.2|Coding|32/48|c.4137A>G|p.Ala1379Ala|4326/8672|4137/6018|1379/2005||;COMMON=1;SAO=0;KGPROD;VLD;RS=2304859;COSMIC_ID=COSM3756117;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,109:109:99:3331,327,0
chr18	2909700	.	C	T	135.6	PASS	GENE=EMILIN2;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.658;DP=14;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.69;ReadPosRankSum=-0.938;SOR=0.283;ANN=T|missense_variant|MODERATE|EMILIN2|EMILIN2|transcript|NM_032048.2|Coding|7/8|c.2707C>T|p.Pro903Ser|2866/4009|2707/3162|903/1053||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=56288451;COSMIC_ID=COSM4418850;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:7,7:14:99:143,0,212
chr18	5244173	.	C	T	875.6	PASS	GENE=LINC00667;AC=1;AF=0.5;AN=2;BaseQRankSum=0.704;DP=36;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.32;ReadPosRankSum=-1.76;SOR=0.801;ANN=T|non_coding_exon_variant|MODIFIER|LINC00667|LINC00667|transcript|NR_015389.1|Noncoding|3/3|n.1645C>T||||||;SAO=0;VLD;RS=1062837	GT:AD:DP:GQ:PL	0/1:7,29:36:99:883,0,101
chr18	5245411	.	T	G	568.6	PASS	GENE=LINC00667;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.949;DP=18;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=31.59;ReadPosRankSum=0.053;SOR=0.693;ANN=G|non_coding_exon_variant|MODIFIER|LINC00667|LINC00667|transcript|NR_015389.1|Noncoding|3/3|n.2883T>G||||||;SAO=0;KGPROD;RS=4548972	GT:AD:DP:GQ:PL	0/1:4,14:18:99:576,0,199
chr18	6462419	.	G	A	3314.03	PASS	GENE=L3MBTL4-LINC01387;AC=2;AF=1;AN=2;BaseQRankSum=-3.02;DP=121;ExcessHet=3.0103;FS=5.978;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.39;ReadPosRankSum=1.895;SOR=0.084;ANN=A|intergenic_region|MODIFIER|L3MBTL4-LINC01387|L3MBTL4-LINC01387|intergenic_region|L3MBTL4-LINC01387|||n.6462419G>A||||||	GT:AD:DP:GQ:PL	1/1:3,118:121:99:3328,239,0
chr18	6462665	.	C	A	506.02	PASS	GENE=L3MBTL4-LINC01387;AC=2;AF=1;AN=2;BaseQRankSum=1.924;DP=18;ExcessHet=3.0103;FS=3.274;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.11;ReadPosRankSum=0.844;SOR=0.515;ANN=A|intergenic_region|MODIFIER|L3MBTL4-LINC01387|L3MBTL4-LINC01387|intergenic_region|L3MBTL4-LINC01387|||n.6462665C>A||||||;SAO=0;RS=372180497	GT:AD:DP:GQ:PL	1/1:2,16:18:33:520,33,0
chr18	6462803	.	C	G	639.03	PASS	GENE=L3MBTL4-LINC01387;AC=2;AF=1;AN=2;DP=20;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.95;SOR=1.127;ANN=G|intergenic_region|MODIFIER|L3MBTL4-LINC01387|L3MBTL4-LINC01387|intergenic_region|L3MBTL4-LINC01387|||n.6462803C>G||||||	GT:AD:DP:GQ:PL	1/1:0,20:20:59:653,59,0
chr18	8825192	.	A	G	37.28	PASS	GENE=MTCL1;AC=2;AF=1;AN=2;DP=2;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=18.64;SOR=0.693;ANN=G|synonymous_variant|LOW|MTCL1|MTCL1|transcript|NM_015210.3|Coding|15/17|c.3684A>G|p.Gly1228Gly|3826/6092|3684/4761|1228/1586||;COMMON=1;SAO=0;KGPROD;VLD;RS=581894;COSMIC_ID=COSM438417;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,2:2:6:49,6,0
chr18	9117867	.	T	C	2684.6	PASS	GENE=NDUFV2;AC=1;AF=0.5;AN=2;BaseQRankSum=-4.232;DP=304;ExcessHet=3.0103;FS=2.056;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.83;ReadPosRankSum=5.327;SOR=0.571;ANN=C|missense_variant|MODERATE|NDUFV2|NDUFV2|transcript|NM_021074.4|Coding|2/8|c.86T>C|p.Val29Ala|200/930|86/750|29/249||;COMMON=1;PM;NSM;SAO=1;KGPROD;VLD;RS=906807;PMC;COSMIC_ID=COSM3773839;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:206,98:304:99:2692,0,6808
chr18	9255982	.	A	G	500.6	PASS	GENE=ANKRD12;AC=1;AF=0.5;AN=2;BaseQRankSum=0;DP=32;ExcessHet=3.0103;FS=1.428;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.64;ReadPosRankSum=0.984;SOR=1.201;ANN=G|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_015208.4|Coding|9/13|c.2717A>G|p.Lys906Arg|2981/11312|2717/6189|906/2062||,G|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_001083625.2|Coding|8/12|c.2648A>G|p.Lys883Arg|2912/11243|2648/6120|883/2039||,G|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_001204056.1|Coding|8/12|c.2648A>G|p.Lys883Arg|3010/11341|2648/6120|883/2039||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=4798791;COSMIC_ID=COSM4000482;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:15,17:32:99:508,0,420
chr18	9256258	.	T	C	145.6	PASS	GENE=ANKRD12;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.602;DP=16;ExcessHet=3.0103;FS=8.383;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.1;ReadPosRankSum=0.435;SOR=2.252;ANN=C|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_015208.4|Coding|9/13|c.2993T>C|p.Leu998Ser|3257/11312|2993/6189|998/2062||,C|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_001083625.2|Coding|8/12|c.2924T>C|p.Leu975Ser|3188/11243|2924/6120|975/2039||,C|missense_variant|MODERATE|ANKRD12|ANKRD12|transcript|NM_001204056.1|Coding|8/12|c.2924T>C|p.Leu975Ser|3286/11341|2924/6120|975/2039||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=34996750;COSMIC_ID=COSM6213076;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=lymphoid_neoplasm -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:10,6:16:99:153,0,292
chr18	10616992	.	A	G	445.03	PASS	GENE=NAPG-LOC101927410;AC=2;AF=1;AN=2;DP=14;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.79;SOR=1.329;ANN=G|intergenic_region|MODIFIER|NAPG-LOC101927410|NAPG-LOC101927410|intergenic_region|NAPG-LOC101927410|||n.10616992A>G||||||;SAO=0;RS=66522105	GT:AD:DP:GQ:PL	1/1:0,14:14:42:459,42,0
chr18	10691246	.	G	A	822.6	PASS	GENE=PIEZO2;AC=1;AF=0.5;AN=2;BaseQRankSum=3.37;DP=86;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.57;ReadPosRankSum=1.282;SOR=0.784;ANN=A|synonymous_variant|LOW|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|44/52|c.6987C>T|p.Tyr2329Tyr|7161/9713|6987/8259|2329/2752||;COMMON=0;SAO=0;KGPROD;VLD;RS=72970080	GT:AD:DP:GQ:PL	0/1:57,29:86:99:830,0,1481
chr18	10691357	.	G	A	5990.03	PASS	GENE=PIEZO2;AC=2;AF=1;AN=2;DP=183;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.91;SOR=0.857;ANN=A|synonymous_variant|LOW|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|44/52|c.6876C>T|p.Ala2292Ala|7050/9713|6876/8259|2292/2752||;COMMON=1;SAO=0;KGPROD;VLD;RS=3748421;COSMIC_ID=COSM5618865;TISSUE=breast;TUMOR=carcinoma -- ductal_carcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,182:182:99:6004,545,0
chr18	10696227	.	C	T	3550.03	PASS	GENE=PIEZO2;AC=2;AF=1;AN=2;BaseQRankSum=1.734;DP=97;ExcessHet=3.0103;FS=3.147;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.86;ReadPosRankSum=1.519;SOR=0.356;ANN=T|synonymous_variant|LOW|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|43/52|c.6696G>A|p.Pro2232Pro|6870/9713|6696/8259|2232/2752||;COMMON=1;SAO=0;KGPROD;VLD;RS=2277860;COSMIC_ID=COSM5438428;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,96:97:99:3564,267,0
chr18	10705417	.	G	A	916.6	PASS	GENE=PIEZO2;AC=1;AF=0.5;AN=2;BaseQRankSum=3.688;DP=74;ExcessHet=3.0103;FS=4.556;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.56;ReadPosRankSum=-0.168;SOR=0.702;ANN=A|synonymous_variant|LOW|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|37/52|c.5577C>T|p.Asp1859Asp|5751/9713|5577/8259|1859/2752||	GT:AD:DP:GQ:PL	0/1:42,31:73:99:924,0,1005
chr18	10759840	.	C	A	508.6	PASS	GENE=PIEZO2;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.802;DP=43;ExcessHet=3.0103;FS=4.365;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.83;ReadPosRankSum=-0.195;SOR=0.789;ANN=A|missense_variant|MODERATE|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|23/52|c.3443G>T|p.Cys1148Phe|3617/9713|3443/8259|1148/2752||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=35033671;COSMIC_ID=COSM6351089;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:22,21:43:99:516,0,623
chr18	11143926	.	T	C	92.6	PASS	GENE=PIEZO2;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.655;DP=13;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.12;ReadPosRankSum=-0.379;SOR=0.527;ANN=C|intron_variant|MODIFIER|PIEZO2|PIEZO2|transcript|NM_022068.3|Coding|1/51|c.64+4598A>G||||||	GT:AD:DP:GQ:PL	0/1:9,4:13:99:100,0,267
chr18	11883610	.	T	G	46.6	PASS	GENE=MPPE1,GNAL;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.124;DP=12;ExcessHet=3.0103;FS=8.195;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.88;ReadPosRankSum=-2.052;SOR=2.225;ANN=G|3_prime_UTR_variant|MODIFIER|GNAL|GNAL|transcript|NM_182978.3|Coding|12/12|c.*2476T>G|||||2476|,G|3_prime_UTR_variant|MODIFIER|MPPE1|MPPE1|transcript|NM_023075.5|Coding|11/11|c.*834A>C|||||834|,G|3_prime_UTR_variant|MODIFIER|GNAL|GNAL|transcript|NM_001142339.2|Coding|13/13|c.*2476T>G|||||2476|,G|3_prime_UTR_variant|MODIFIER|GNAL|GNAL|transcript|NM_001261443.1|Coding|13/13|c.*2476T>G|||||2476|,G|3_prime_UTR_variant|MODIFIER|GNAL|GNAL|transcript|NM_001261444.1|Coding|8/8|c.*2476T>G|||||2476|,G|3_prime_UTR_variant|MODIFIER|MPPE1|MPPE1|transcript|NM_001242904.1|Coding|8/8|c.*834A>C|||||834|,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040241.1|Noncoding|12/12|n.2986A>C||||||,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040242.1|Noncoding|13/13|n.2854A>C||||||,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040243.1|Noncoding|12/12|n.2989A>C||||||	GT:AD:DP:GQ:PL	0/1:10,2:12:54:54,0,1054
chr18	11886563	.	C	G	1160.6	PASS	GENE=MPPE1;AC=1;AF=0.5;AN=2;BaseQRankSum=0.925;DP=64;ExcessHet=3.0103;FS=1.024;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.13;ReadPosRankSum=1.456;SOR=0.476;ANN=G|missense_variant|MODERATE|MPPE1|MPPE1|transcript|NM_023075.5|Coding|9/11|c.802G>C|p.Ala268Pro|1598/2959|802/1191|268/396||,G|intron_variant|MODIFIER|MPPE1|MPPE1|transcript|NM_001242904.1|Coding|6/7|c.678+353G>C||||||,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040241.1|Noncoding|9/12|n.1598G>C||||||,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040242.1|Noncoding|10/13|n.1466G>C||||||,G|non_coding_exon_variant|MODIFIER|MPPE1|MPPE1|transcript|NR_040243.1|Noncoding|9/12|n.1601G>C||||||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=662515;COSMIC_ID=COSM4130912;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:23,41:64:99:1168,0,566
chr18	12308793	.	G	C	803.6	PASS	GENE=TUBB6;AC=1;AF=0.5;AN=2;BaseQRankSum=0.775;DP=64;ExcessHet=3.0103;FS=3.594;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.56;ReadPosRankSum=-3.652;SOR=1.244;ANN=C|splice_region_variant&synonymous_variant|LOW|TUBB6|TUBB6|transcript|NM_032525.1|Coding|2/4|c.165G>C|p.Ser55Ser|200/1815|165/1341|55/446||;COMMON=1;SAO=0;KGPROD;VLD;RS=11267036;COSMIC_ID=COSM3756071;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:34,30:64:99:811,0,1913
chr18	12348285	.	T	C	986.6	PASS	GENE=AFG3L2;AC=1;AF=0.5;AN=2;BaseQRankSum=-3.143;DP=88;ExcessHet=3.0103;FS=5.667;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.21;ReadPosRankSum=0.57;SOR=0.307;ANN=C|synonymous_variant|LOW|AFG3L2|AFG3L2|transcript|NM_006796.2|Coding|13/17|c.1650A>G|p.Glu550Glu|1844/3209|1650/2394|550/797||;COMMON=1;SAO=0;KGPROD;VLD;RS=11553521;COSMIC_ID=COSM148398;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:51,37:88:99:994,0,1657
chr18	12351342	.	C	T	1506.6	PASS	GENE=AFG3L2;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.049;DP=95;ExcessHet=3.0103;FS=8.32;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.86;ReadPosRankSum=1.007;SOR=0.324;ANN=T|synonymous_variant|LOW|AFG3L2|AFG3L2|transcript|NM_006796.2|Coding|11/17|c.1389G>A|p.Leu463Leu|1583/3209|1389/2394|463/797||;COMMON=1;SAO=0;KGPROD;VLD;RS=11080572;COSMIC_ID=COSM148399;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:46,49:95:99:1514,0,1400
chr18	12785904	.	A	C	46.6	PASS	GENE=PTPN2;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.085;DP=12;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.88;ReadPosRankSum=-1.617;SOR=0.693;ANN=C|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_001207013.1|Coding|10/10|c.1212-61T>G||||||,C|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080422.2|Coding|9/9|c.1143-61T>G||||||,C|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080423.2|Coding|8/8|c.1041-61T>G||||||	GT:AD:DP:GQ:PL	0/1:10,2:12:54:54,0,684
chr18	12785905	.	T	G	46.6	PASS	GENE=PTPN2;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.266;DP=12;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.88;ReadPosRankSum=-1.617;SOR=0.693;ANN=G|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_001207013.1|Coding|10/10|c.1212-62A>C||||||,G|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080422.2|Coding|9/9|c.1143-62A>C||||||,G|intron_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080423.2|Coding|8/8|c.1041-62A>C||||||	GT:AD:DP:GQ:PL	0/1:10,2:12:54:54,0,684
chr18	12884201	.	A	G	33.6	PASS	GENE=PTPN2;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.507;DP=15;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.24;ReadPosRankSum=-2.134;SOR=0.446;ANN=G|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_002828.3|Coding|1/9|c.-61T>C|||||61|,G|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_001207013.1|Coding|1/11|c.-61T>C|||||61|,G|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080422.2|Coding|1/10|c.-61T>C|||||61|,G|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080423.2|Coding|1/9|c.-61T>C|||||61|	GT:AD:DP:GQ:PL	0/1:13,2:15:41:41,0,781
chr18	12884202	.	C	A	33.6	PASS	GENE=PTPN2;AC=1;AF=0.5;AN=2;BaseQRankSum=2.384;DP=15;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.24;ReadPosRankSum=-2.134;SOR=0.446;ANN=A|5_prime_UTR_premature_start_codon_gain_variant|LOW|PTPN2|PTPN2|transcript|NM_002828.3|Coding|1/9|c.-62G>T||||||,A|5_prime_UTR_premature_start_codon_gain_variant|LOW|PTPN2|PTPN2|transcript|NM_001207013.1|Coding|1/11|c.-62G>T||||||,A|5_prime_UTR_premature_start_codon_gain_variant|LOW|PTPN2|PTPN2|transcript|NM_080422.2|Coding|1/10|c.-62G>T||||||,A|5_prime_UTR_premature_start_codon_gain_variant|LOW|PTPN2|PTPN2|transcript|NM_080423.2|Coding|1/9|c.-62G>T||||||,A|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_002828.3|Coding|1/9|c.-62G>T|||||62|,A|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_001207013.1|Coding|1/11|c.-62G>T|||||62|,A|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080422.2|Coding|1/10|c.-62G>T|||||62|,A|5_prime_UTR_variant|MODIFIER|PTPN2|PTPN2|transcript|NM_080423.2|Coding|1/9|c.-62G>T|||||62|	GT:AD:DP:GQ:PL	0/1:13,2:15:41:41,0,781
chr18	13116432	.	G	T	1543.6	PASS	GENE=CEP192;AC=1;AF=0.5;AN=2;BaseQRankSum=1.934;DP=99;ExcessHet=3.0103;FS=0.763;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.59;ReadPosRankSum=0.723;SOR=0.556;ANN=T|missense_variant|MODERATE|CEP192|CEP192|transcript|NM_032142.3|Coding|43/45|c.7346G>T|p.Arg2449Leu|7426/7976|7346/7614|2449/2537||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=1786263;COSMIC_ID=COSM5001134;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:42,57:99:99:1551,0,912
chr18	19154143	.	G	A	276.6	PASS	GENE=ESCO1;AC=1;AF=0.5;AN=2;BaseQRankSum=1.386;DP=26;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.64;ReadPosRankSum=1.298;SOR=0.766;ANN=A|missense_variant|MODERATE|ESCO1|ESCO1|transcript|NM_052911.2|Coding|4/12|c.662C>T|p.Thr221Met|1596/4499|662/2523|221/840||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=13381941;COSMIC_ID=COSM3756093;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:15,11:26:99:284,0,331
chr18	20953720	.	G	A	100.6	PASS	GENE=TMEM241;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.125;DP=16;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.29;ReadPosRankSum=1.076;SOR=0.836;ANN=A|missense_variant|MODERATE|TMEM241|TMEM241|transcript|NM_032933.4|Coding|7/15|c.391C>T|p.Leu131Phe|500/2992|391/891|131/296||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=8099409;COSMIC_ID=COSM3756096;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:11,5:16:99:108,0,300
chr18	21119777	.	G	A	2110.03	PASS	GENE=NPC1;AC=2;AF=1;AN=2;DP=55;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.34;SOR=1.159;ANN=A|splice_region_variant&synonymous_variant|LOW|NPC1|NPC1|transcript|NM_000271.4|Coding|18/25|c.2793C>T|p.Asn931Asn|3067/4814|2793/3837|931/1278||;COMMON=1;PM;SAO=1;KGPROD;VLD;RS=1140458;COSMIC_ID=COSM5905079;TISSUE=skin;TUMOR=carcinoma -- basal_cell_carcinoma;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,55:55:99:2124,165,0
chr18	21124945	.	C	G	1683.03	PASS	GENE=NPC1;AC=2;AF=1;AN=2;DP=52;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.37;SOR=1.358;ANN=G|missense_variant|MODERATE|NPC1|NPC1|transcript|NM_000271.4|Coding|12/25|c.1926G>C|p.Met642Ile|2200/4814|1926/3837|642/1278||	GT:AD:DP:GQ:PL	1/1:0,52:52:99:1697,155,0
chr18	21511089	.	A	G	37.28	PASS	GENE=LAMA3;AC=2;AF=1;AN=2;DP=2;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=18.64;SOR=0.693;ANN=G|missense_variant|MODERATE|LAMA3|LAMA3|transcript|NM_198129.1|Coding|65/75|c.8500A>G|p.Ser2834Gly|8586/10505|8500/10002|2834/3333||,G|missense_variant|MODERATE|LAMA3|LAMA3|transcript|NM_001127717.1|Coding|64/74|c.8332A>G|p.Ser2778Gly|8418/10337|8332/9834|2778/3277||,G|missense_variant|MODERATE|LAMA3|LAMA3|transcript|NM_000227.3|Coding|28/38|c.3673A>G|p.Ser1225Gly|3698/5617|3673/5175|1225/1724||,G|missense_variant|MODERATE|LAMA3|LAMA3|transcript|NM_001127718.1|Coding|27/37|c.3505A>G|p.Ser1169Gly|3530/5449|3505/5007|1169/1668||;COMMON=0;NSM;SAO=0;KGPROD;VLD;RS=1154233;COSMIC_ID=COSM4590317;TISSUE=upper_aerodigestive_tract;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM=NEUTRAL;SOMATIC=Variant of unknown origin	GT:AD:DP:GQ:PL	1/1:0,2:2:6:49,6,0
chr18	21705440	.	C	T	789.6	PASS	GENE=TTC39C;AC=1;AF=0.5;AN=2;BaseQRankSum=3.326;DP=44;ExcessHet=3.0103;FS=1.13;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.95;ReadPosRankSum=2.328;SOR=0.527;ANN=T|missense_variant|MODERATE|TTC39C|TTC39C|transcript|NM_001135993.1|Coding|10/14|c.1346C>T|p.Ala449Val|1798/5240|1346/1752|449/583||,T|missense_variant|MODERATE|TTC39C|TTC39C|transcript|NM_153211.3|Coding|10/14|c.1163C>T|p.Ala388Val|1445/4887|1163/1569|388/522||,T|missense_variant|MODERATE|TTC39C|TTC39C|transcript|NM_001292030.1|Coding|5/9|c.425C>T|p.Ala142Val|675/4117|425/831|142/276||;COMMON=0;NSM;SAO=0;KGPROD;RS=72881750	GT:AD:DP:GQ:PL	0/1:21,23:44:99:797,0,571
chr18	21739725	.	T	C	37.28	PASS	GENE=CABYR;AC=2;AF=1;AN=2;DP=2;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=18.64;SOR=0.693;ANN=C|synonymous_variant|LOW|CABYR|CABYR|transcript|NM_138643.2|Coding|3/4|c.537T>C|p.Pro179Pro|795/1188|537/846|179/281||,C|synonymous_variant|LOW|CABYR|CABYR|transcript|NM_153769.2|Coding|5/6|c.831T>C|p.Pro277Pro|1018/1411|831/1140|277/379||,C|synonymous_variant|LOW|CABYR|CABYR|transcript|NM_138644.2|Coding|5/6|c.831T>C|p.Pro277Pro|891/1284|831/1140|277/379||,C|3_prime_UTR_variant|MODIFIER|CABYR|CABYR|transcript|NM_012189.3|Coding|5/6|c.*306T>C|||||2778|,C|3_prime_UTR_variant|MODIFIER|CABYR|CABYR|transcript|NM_153768.2|Coding|4/5|c.*306T>C|||||2778|,C|intron_variant|MODIFIER|CABYR|CABYR|transcript|NM_153770.2|Coding|4/5|c.542-185T>C||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=1049684;COSMIC_ID=COSM4415684;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=lymphoid_neoplasm -- diffuse_large_B_cell_lymphoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,2:2:6:49,6,0
chr18	22020543	.	C	G	853.03	PASS	GENE=IMPACT;AC=2;AF=1;AN=2;DP=28;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.47;SOR=0.836;ANN=G|missense_variant|MODERATE|IMPACT|IMPACT|transcript|NM_018439.3|Coding|6/11|c.451C>G|p.Leu151Val|563/3758|451/963|151/320||;COMMON=1;PM;SAO=0;KGPROD;VLD;RS=677688;PMC;COSMIC_ID=COSM5425327;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,28:28:84:867,84,0
chr18	23617858	.	G	A	798.03	PASS	GENE=SS18;AC=2;AF=1;AN=2;DP=22;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=37.55;SOR=1.329;ANN=A|intron_variant|MODIFIER|SS18|SS18|transcript|NM_001007559.1|Coding|7/10|c.880+661C>T||||||,A|intron_variant|MODIFIER|SS18|SS18|transcript|NM_005637.2|Coding|7/9|c.880+661C>T||||||;COMMON=0;SAO=0;KGPROD;RS=674705	GT:AD:DP:GQ:PL	1/1:0,22:22:66:812,66,0
chr18	23865851	.	C	T	404.6	PASS	GENE=TAF4B;AC=1;AF=0.5;AN=2;BaseQRankSum=2.571;DP=27;ExcessHet=3.0103;FS=1.527;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.99;ReadPosRankSum=0.461;SOR=1.179;ANN=T|synonymous_variant|LOW|TAF4B|TAF4B|transcript|NM_001293725.1|Coding|7/15|c.978C>T|p.Ser326Ser|1029/4328|978/2604|326/867||,T|synonymous_variant|LOW|TAF4B|TAF4B|transcript|NM_005640.2|Coding|7/15|c.978C>T|p.Ser326Ser|1029/4313|978/2589|326/862||,T|non_coding_exon_variant|MODIFIER|TAF4B|TAF4B|transcript|NR_121653.1|Noncoding|7/16|n.1029C>T||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=12456749;COSMIC_ID=COSM3756102;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:14,13:27:99:412,0,322
chr18	23872235	.	A	G	408.6	PASS	GENE=TAF4B;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.239;DP=35;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.67;ReadPosRankSum=0.746;SOR=0.829;ANN=G|missense_variant|MODERATE|TAF4B|TAF4B|transcript|NM_001293725.1|Coding|8/15|c.1631A>G|p.Asn544Ser|1682/4328|1631/2604|544/867||,G|missense_variant|MODERATE|TAF4B|TAF4B|transcript|NM_005640.2|Coding|8/15|c.1616A>G|p.Asn539Ser|1667/4313|1616/2589|539/862||,G|non_coding_exon_variant|MODIFIER|TAF4B|TAF4B|transcript|NR_121653.1|Noncoding|8/16|n.1667A>G||||||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=12963653;COSMIC_ID=COSM3756104;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:19,16:35:99:416,0,499
chr18	29104698	.	C	T	1065.6	PASS	GENE=DSG2;AC=1;AF=0.5;AN=2;BaseQRankSum=3.293;DP=91;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.71;ReadPosRankSum=0.38;SOR=0.673;ANN=T|synonymous_variant|LOW|DSG2|DSG2|transcript|NM_001943.3|Coding|8/15|c.861C>T|p.Asn287Asn|1049/5653|861/3357|287/1118||;COMMON=1;SAO=0;KGPROD;VLD;RS=2230233;COSMIC_ID=COSM3756122;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:54,37:91:99:1073,0,1337
chr18	29122799	.	G	A	2105.6	PASS	GENE=DSG2,LOC100652770;AC=1;AF=0.5;AN=2;BaseQRankSum=4.998;DP=135;ExcessHet=3.0103;FS=0.636;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.6;ReadPosRankSum=0.705;SOR=0.614;ANN=A|missense_variant|MODERATE|DSG2|DSG2|transcript|NM_001943.3|Coding|14/15|c.2318G>A|p.Arg773Lys|2506/5653|2318/3357|773/1118||,A|intron_variant|MODIFIER|LOC100652770|LOC100652770|transcript|NR_045216.1|Noncoding|5/5|n.1810+266C>T||||||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2278792;COSMIC_ID=COSM3766248;TISSUE=liver;TUMOR=carcinoma -- hepatocellular_carcinoma;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:69,66:135:99:2113,0,1893
chr18	29126670	.	T	C	4577.6	PASS	GENE=DSG2,LOC100652770;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.205;DP=330;ExcessHet=3.0103;FS=2.337;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.87;ReadPosRankSum=-1.402;SOR=0.671;ANN=C|synonymous_variant|LOW|DSG2|DSG2|transcript|NM_001943.3|Coding|15/15|c.3321T>C|p.Val1107Val|3509/5653|3321/3357|1107/1118||,C|intron_variant|MODIFIER|LOC100652770|LOC100652770|transcript|NR_045216.1|Noncoding|3/5|n.1346-801A>G||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=1791235;COSMIC_ID=COSM3756124;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:158,172:330:99:4585,0,4492
chr18	29432624	.	T	C	1070.6	PASS	GENE=TRAPPC8;AC=1;AF=0.5;AN=2;BaseQRankSum=2.002;DP=63;ExcessHet=3.0103;FS=5.118;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.99;ReadPosRankSum=0.769;SOR=0.371;ANN=C|missense_variant&splice_region_variant|MODERATE|TRAPPC8|TRAPPC8|transcript|NM_014939.3|Coding|23/29|c.3436A>G|p.Thr1146Ala|3800/6254|3436/4308|1146/1435||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3737374;COSMIC_ID=COSM4153948;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:28,35:63:99:1078,0,750
chr18	29454644	.	A	G	395.6	PASS	GENE=TRAPPC8;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.137;DP=32;ExcessHet=3.0103;FS=1.428;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.36;ReadPosRankSum=0.288;SOR=0.625;ANN=G|synonymous_variant|LOW|TRAPPC8|TRAPPC8|transcript|NM_014939.3|Coding|13/29|c.1752T>C|p.Tyr584Tyr|2116/6254|1752/4308|584/1435||;COMMON=1;SAO=0;KGPROD;VLD;RS=2276145;COSMIC_ID=COSM4000392;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:19,13:32:99:403,0,576
chr18	29488804	.	A	G	833.6	PASS	GENE=TRAPPC8;AC=1;AF=0.5;AN=2;BaseQRankSum=-4.76;DP=73;ExcessHet=3.0103;FS=3.155;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.42;ReadPosRankSum=0.499;SOR=0.413;ANN=G|synonymous_variant|LOW|TRAPPC8|TRAPPC8|transcript|NM_014939.3|Coding|7/29|c.1035T>C|p.His345His|1399/6254|1035/4308|345/1435||;COMMON=1;SAO=0;KGPROD;VLD;RS=12326860;COSMIC_ID=COSM4000393;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:33,40:73:99:841,0,1048
chr18	29497573	.	A	G	1135.03	PASS	GENE=TRAPPC8;AC=2;AF=1;AN=2;DP=42;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.68;SOR=0.741;ANN=G|missense_variant|MODERATE|TRAPPC8|TRAPPC8|transcript|NM_014939.3|Coding|3/29|c.410T>C|p.Leu137Ser|774/6254|410/4308|137/1435||;COMMON=0;SAO=0;KGPROD;VLD;RS=6506948	GT:AD:DP:GQ:PL	1/1:0,41:41:99:1149,123,0
chr18	29991618	.	C	T	886.03	PASS	GENE=GAREM;AC=2;AF=1;AN=2;DP=20;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.85;SOR=4.615;ANN=T|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_001242409.1|Coding|1/5|c.122-18620G>A||||||,T|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_022751.2|Coding|1/5|c.122-18620G>A||||||;SAO=0;RS=3980740	GT:AD:DP:GQ:PL	1/1:0,20:20:60:900,60,0
chr18	29991623	.	T	C	886.03	PASS	GENE=GAREM;AC=2;AF=1;AN=2;DP=20;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.04;SOR=4.615;ANN=C|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_001242409.1|Coding|1/5|c.122-18625A>G||||||,C|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_022751.2|Coding|1/5|c.122-18625A>G||||||;SAO=0;RS=3980741	GT:AD:DP:GQ:PL	1/1:0,20:20:60:900,60,0
chr18	29992004	.	C	T	927.03	PASS	GENE=GAREM;AC=2;AF=1;AN=2;DP=33;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.09;SOR=1.022;ANN=T|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_001242409.1|Coding|1/5|c.122-19006G>A||||||,T|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_022751.2|Coding|1/5|c.122-19006G>A||||||;SAO=0;RS=4104672	GT:AD:DP:GQ:PL	1/1:0,33:33:99:941,99,0
chr18	29992124	.	G	A	1235.03	PASS	GENE=GAREM;AC=2;AF=1;AN=2;DP=37;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.38;SOR=1.27;ANN=A|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_001242409.1|Coding|1/5|c.122-19126C>T||||||,A|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_022751.2|Coding|1/5|c.122-19126C>T||||||;SAO=0;RS=4104673	GT:AD:DP:GQ:PL	1/1:0,37:37:99:1249,111,0
chr18	29992487	.	T	C	414.02	PASS	GENE=GAREM;AC=2;AF=1;AN=2;DP=14;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.85;SOR=1.609;ANN=C|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_001242409.1|Coding|1/5|c.122-19489A>G||||||,C|intron_variant|MODIFIER|GAREM|GAREM|transcript|NM_022751.2|Coding|1/5|c.122-19489A>G||||||	GT:AD:DP:GQ:PL	1/1:0,13:13:39:428,39,0
chr18	32917644	.	T	C	2723.03	PASS	GENE=ZNF24;AC=2;AF=1;AN=2;BaseQRankSum=1.743;DP=77;ExcessHet=3.0103;FS=3.067;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.43;ReadPosRankSum=1.713;SOR=0.306;ANN=C|missense_variant|MODERATE|ZNF24|ZNF24|transcript|NM_006965.2|Coding|4/4|c.659A>G|p.Asn220Ser|845/6311|659/1107|220/368||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2032729;COSMIC_ID=COSM3756139;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,76:77:99:2737,221,0
chr18	33243613	.	C	T	920.6	PASS	GENE=GALNT1;AC=1;AF=0.5;AN=2;BaseQRankSum=1.683;DP=64;ExcessHet=3.0103;FS=0.997;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.38;ReadPosRankSum=2.343;SOR=0.527;ANN=T|missense_variant|MODERATE|GALNT1|GALNT1|transcript|NM_020474.3|Coding|2/11|c.161C>T|p.Pro54Leu|255/3838|161/1680|54/559||;COMMON=0;NSM;SAO=0;KGPROD;RS=72964406	GT:AD:DP:GQ:PL	0/1:34,30:64:99:928,0,958
chr18	33694120	.	G	A	2846.6	PASS	GENE=SLC39A6;AC=1;AF=0.5;AN=2;BaseQRankSum=2.911;DP=171;ExcessHet=3.0103;FS=1.226;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.65;ReadPosRankSum=0.978;SOR=0.573;ANN=A|synonymous_variant|LOW|SLC39A6|SLC39A6|transcript|NM_012319.3|Coding|7/10|c.1783C>T|p.Leu595Leu|2073/3620|1783/2268|595/755||,A|synonymous_variant|LOW|SLC39A6|SLC39A6|transcript|NM_001099406.1|Coding|6/8|c.958C>T|p.Leu320Leu|1275/1666|958/1302|320/433||;COMMON=1;PM;SAO=0;KGPROD;VLD;RS=1050631;PMC;COSMIC_ID=COSM5983431;TISSUE=upper_aerodigestive_tract;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:80,91:171:99:2854,0,2278
chr18	33718326	.	A	C	2120.6	PASS	GENE=ELP2;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.638;DP=137;ExcessHet=3.0103;FS=0.648;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.48;ReadPosRankSum=0.412;SOR=0.791;ANN=C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242875.1|Coding|4/23|c.382A>C|p.Thr128Pro|442/2820|382/2676|128/891||,C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242879.1|Coding|4/19|c.382A>C|p.Thr128Pro|442/2411|382/2271|128/756||,C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242876.1|Coding|4/21|c.382A>C|p.Thr128Pro|442/2610|382/2466|128/821||,C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242877.1|Coding|4/21|c.382A>C|p.Thr128Pro|442/2547|382/2403|128/800||,C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242878.1|Coding|4/20|c.382A>C|p.Thr128Pro|442/2415|382/2271|128/756||,C|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_018255.2|Coding|4/22|c.382A>C|p.Thr128Pro|442/2625|382/2481|128/826||,C|non_coding_exon_variant|MODIFIER|ELP2|ELP2|transcript|NR_040110.1|Noncoding|4/22|n.442A>C||||||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=1785934;COSMIC_ID=COSM5000536;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:54,83:137:99:2128,0,1401
chr18	33725931	.	G	A	1138.6	PASS	GENE=ELP2;AC=1;AF=0.5;AN=2;BaseQRankSum=2.973;DP=76;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.98;ReadPosRankSum=0.574;SOR=0.638;ANN=A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242875.1|Coding|11/23|c.1108G>A|p.Val370Met|1168/2820|1108/2676|370/891||,A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242879.1|Coding|7/19|c.703G>A|p.Val235Met|763/2411|703/2271|235/756||,A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242876.1|Coding|10/21|c.1030G>A|p.Val344Met|1090/2610|1030/2466|344/821||,A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242877.1|Coding|9/21|c.835G>A|p.Val279Met|895/2547|835/2403|279/800||,A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_001242878.1|Coding|9/20|c.835G>A|p.Val279Met|895/2415|835/2271|279/756||,A|missense_variant|MODERATE|ELP2|ELP2|transcript|NM_018255.2|Coding|10/22|c.913G>A|p.Val305Met|973/2625|913/2481|305/826||,A|non_coding_exon_variant|MODIFIER|ELP2|ELP2|transcript|NR_040110.1|Noncoding|10/22|n.973G>A||||||;COMMON=1;PM;NSM;SAO=0;KGPROD;VLD;RS=1785928;PMC;COSMIC_ID=COSM1388588;TISSUE=upper_aerodigestive_tract;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:41,35:76:99:1146,0,1324
chr18	33750046	.	C	T	1689.6	PASS	GENE=ELP2;AC=1;AF=0.5;AN=2;BaseQRankSum=3.475;DP=83;ExcessHet=3.0103;FS=4.366;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.36;ReadPosRankSum=-1.72;SOR=0.636;ANN=T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_001242875.1|Coding|21/23|c.2292C>T|p.Cys764Cys|2352/2820|2292/2676|764/891||,T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_001242879.1|Coding|17/19|c.1887C>T|p.Cys629Cys|1947/2411|1887/2271|629/756||,T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_001242876.1|Coding|19/21|c.2082C>T|p.Cys694Cys|2142/2610|2082/2466|694/821||,T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_001242877.1|Coding|19/21|c.2019C>T|p.Cys673Cys|2079/2547|2019/2403|673/800||,T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_001242878.1|Coding|18/20|c.1887C>T|p.Cys629Cys|1947/2415|1887/2271|629/756||,T|synonymous_variant|LOW|ELP2|ELP2|transcript|NM_018255.2|Coding|20/22|c.2097C>T|p.Cys699Cys|2157/2625|2097/2481|699/826||,T|non_coding_exon_variant|MODIFIER|ELP2|ELP2|transcript|NR_040110.1|Noncoding|20/22|n.2105C>T||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=8299;COSMIC_ID=COSM1388592;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:31,52:83:99:1697,0,682
chr18	34647323	.	T	A	75.8	PASS	GENE=KIAA1328;AC=2;AF=1;AN=2;DP=3;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=25.27;SOR=1.179;ANN=A|synonymous_variant|LOW|KIAA1328|KIAA1328|transcript|NM_020776.1|Coding|7/10|c.1047T>A|p.Gly349Gly|1069/4854|1047/1734|349/577||;COMMON=1;SAO=0;KGPROD;VLD;RS=3747896;COSMIC_ID=COSM6353947;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,3:3:9:89,9,0
chr18	34664093	.	A	G	105.1	PASS	GENE=KIAA1328;AC=2;AF=1;AN=2;DP=4;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.27;SOR=0.693;ANN=G|intron_variant|MODIFIER|KIAA1328|KIAA1328|transcript|NM_020776.1|Coding|7/9|c.1232+16585A>G||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=323295;COSMIC_ID=COSM3821430;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,4:4:12:119,12,0
chr18	42532923	.	T	C	52.6	PASS	GENE=SETBP1;AC=1;AF=0.5;AN=2;BaseQRankSum=2.1;DP=8;ExcessHet=3.0103;FS=3.332;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.58;ReadPosRankSum=1.068;SOR=0.105;ANN=C|synonymous_variant|LOW|SETBP1|SETBP1|transcript|NM_015559.2|Coding|4/6|c.3618T>C|p.His1206His|3914/9899|3618/4791|1206/1596||;COMMON=1;SAO=0;KGPROD;VLD;RS=34882016;COSMIC_ID=COSM6494528;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Variant of unknown origin	GT:AD:DP:GQ:PL	0/1:6,2:8:60:60,0,170
chr18	42533130	.	A	G	86.6	PASS	GENE=SETBP1;AC=1;AF=0.5;AN=2;BaseQRankSum=0;DP=9;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.62;ReadPosRankSum=0;SOR=1.179;ANN=G|synonymous_variant|LOW|SETBP1|SETBP1|transcript|NM_015559.2|Coding|4/6|c.3825A>G|p.Ser1275Ser|4121/9899|3825/4791|1275/1596||;COMMON=1;SAO=0;KGPROD;VLD;RS=8096662;COSMIC_ID=COSM6494530;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Variant of unknown origin	GT:AD:DP:GQ:PL	0/1:5,4:9:94:94,0,118
chr18	43669530	.	A	T	37.6	PASS	GENE=ATP5A1;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.287;DP=10;ExcessHet=3.0103;FS=6.99;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.76;ReadPosRankSum=2.287;SOR=0.012;ANN=T|splice_donor_variant&intron_variant|HIGH|ATP5A1|ATP5A1|transcript|NM_001001937.1|Coding|6/12|c.650+2T>A||||||,T|splice_donor_variant&intron_variant|HIGH|ATP5A1|ATP5A1|transcript|NM_001001935.2|Coding|5/11|c.500+2T>A||||||,T|splice_donor_variant&intron_variant|HIGH|ATP5A1|ATP5A1|transcript|NM_001257334.1|Coding|5/11|c.584+2T>A||||||,T|splice_donor_variant&intron_variant|HIGH|ATP5A1|ATP5A1|transcript|NM_001257335.1|Coding|5/11|c.500+2T>A||||||,T|splice_donor_variant&intron_variant|HIGH|ATP5A1|ATP5A1|transcript|NM_004046.5|Coding|5/11|c.650+2T>A||||||	GT:AD:DP:GQ:PL	0/1:8,2:10:45:45,0,368
chr18	43843736	.	T	G	688.03	PASS	GENE=C18orf25;AC=2;AF=1;AN=2;DP=23;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.91;SOR=1.179;ANN=G|3_prime_UTR_variant|MODIFIER|C18orf25|C18orf25|transcript|NM_145055.3|Coding|5/5|c.*655T>G|||||655|,G|3_prime_UTR_variant|MODIFIER|C18orf25|C18orf25|transcript|NM_001008239.2|Coding|4/4|c.*655T>G|||||655|;COMMON=0;SAO=0;KGPROD;RS=9956233	GT:AD:DP:GQ:PL	1/1:0,23:23:69:702,69,0
chr18	45367484	.	A	G	718.03	PASS	GENE=SMAD2;AC=2;AF=1;AN=2;DP=24;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.22;SOR=1.708;ANN=G|3_prime_UTR_variant|MODIFIER|SMAD2|SMAD2|transcript|NM_001003652.3|Coding|11/11|c.*714T>C|||||714|,G|3_prime_UTR_variant|MODIFIER|SMAD2|SMAD2|transcript|NM_005901.5|Coding|11/11|c.*714T>C|||||714|,G|3_prime_UTR_variant|MODIFIER|SMAD2|SMAD2|transcript|NM_001135937.2|Coding|10/10|c.*714T>C|||||714|;COMMON=0;SAO=0;KGPROD;RS=1787187	GT:AD:DP:GQ:PL	1/1:0,23:23:68:732,68,0
chr18	46284587	.	T	C	207	PASS	GENE=CTIF;AC=2;AF=1;AN=2;DP=8;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.87;SOR=0.693;ANN=C|synonymous_variant|LOW|CTIF|CTIF|transcript|NM_001142397.1|Coding|9/13|c.882T>C|p.Leu294Leu|1241/5818|882/1803|294/600||,C|synonymous_variant|LOW|CTIF|CTIF|transcript|NM_014772.2|Coding|8/12|c.882T>C|p.Leu294Leu|1167/5738|882/1797|294/598||;COMMON=1;SAO=0;KGPROD;VLD;RS=1038308;COSMIC_ID=COSM1162539;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,8:8:24:221,24,0
chr18	46385948	.	A	G	44.6	PASS	GENE=CTIF;AC=1;AF=0.5;AN=2;BaseQRankSum=0.674;DP=4;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.15;ReadPosRankSum=1.383;SOR=0.693;ANN=G|3_prime_UTR_variant|MODIFIER|CTIF|CTIF|transcript|NM_001142397.1|Coding|13/13|c.*18A>G|||||18|,G|3_prime_UTR_variant|MODIFIER|CTIF|CTIF|transcript|NM_014772.2|Coding|12/12|c.*18A>G|||||18|;COMMON=1;SAO=0;KGPROD;VLD;RS=3752082;COSMIC_ID=COSM4000409;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:2,2:4:37:52,0,37
chr18	47017820	.	A	G	1778.03	PASS	GENE=RPL17-C18orf32,RPL17;AC=2;AF=1;AN=2;DP=57;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.19;SOR=0.728;ANN=G|splice_region_variant&intron_variant|LOW|RPL17-C18orf32|RPL17-C18orf32|transcript|NM_001199355.1|Coding|1/6|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_000985.4|Coding|2/6|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001199341.1|Coding|2/6|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001199342.1|Coding|3/7|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001199343.1|Coding|3/7|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001199344.1|Coding|2/6|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001035006.2|Coding|2/6|c.41-5T>C||||||,G|splice_region_variant&intron_variant|LOW|RPL17|RPL17|transcript|NM_001199340.1|Coding|3/7|c.41-5T>C||||||,G|intron_variant|MODIFIER|RPL17-C18orf32|RPL17-C18orf32|transcript|NM_001199356.1|Coding|2/6|c.-34+82T>C||||||,G|intron_variant|MODIFIER|RPL17|RPL17|transcript|NM_001199345.1|Coding|2/5|c.-34+82T>C||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=1943676;COSMIC_ID=COSM4000411;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,57:57:99:1792,171,0
chr18	47908556	.	G	A	1439.6	PASS	GENE=SKA1;AC=1;AF=0.5;AN=2;BaseQRankSum=3.262;DP=89;ExcessHet=3.0103;FS=1.724;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.18;ReadPosRankSum=-1.854;SOR=0.738;ANN=A|missense_variant|MODERATE|SKA1|SKA1|transcript|NM_001039535.2|Coding|4/7|c.271G>A|p.Val91Ile|500/2918|271/768|91/255||,A|missense_variant|MODERATE|SKA1|SKA1|transcript|NM_145060.3|Coding|4/7|c.271G>A|p.Val91Ile|455/2873|271/768|91/255||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=6507992;COSMIC_ID=COSM3756158;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:40,49:89:99:1447,0,865
chr18	48577782	.	G	C	528.03	PASS	GENE=SMAD4;AC=2;AF=1;AN=2;DP=18;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.33;SOR=0.914;ANN=C|intron_variant|MODIFIER|SMAD4|SMAD4|transcript|NM_005359.5|Coding|4/11|c.454+2088G>C||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=7229678;COSMIC_ID=COSM6353355;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,18:18:54:542,54,0
chr18	48723217	.	C	T	184	PASS	GENE=MEX3C;AC=2;AF=1;AN=2;DP=8;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23;SOR=0.693;ANN=T|synonymous_variant|LOW|MEX3C|MEX3C|transcript|NM_016626.4|Coding|1/2|c.474G>A|p.Pro158Pro|835/4142|474/1980|158/659||;COMMON=1;SAO=0;KGPROD;RS=35675106;COSMIC_ID=COSM3756163;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,8:8:24:198,24,0
chr18	51933377	.	A	G	1411.03	PASS	GENE=C18orf54-DYNAP;AC=2;AF=1;AN=2;DP=35;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.38;SOR=3.321;ANN=G|intergenic_region|MODIFIER|C18orf54-DYNAP|C18orf54-DYNAP|intergenic_region|C18orf54-DYNAP|||n.51933377A>G||||||	GT:AD:DP:GQ:PL	1/1:0,35:35:99:1425,105,0
chr18	52895531	.	T	C	2312.03	PASS	GENE=TCF4;AC=2;AF=1;AN=2;BaseQRankSum=1.502;DP=82;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.2;ReadPosRankSum=-0.196;SOR=0.743;ANN=C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243226.2|Coding|20/21|c.2247A>G|p.Ser749Ser|2343/8122|2247/2322|749/773||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243236.1|Coding|12/13|c.1449A>G|p.Ser483Ser|1586/7365|1449/1524|483/507||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243234.1|Coding|12/13|c.1461A>G|p.Ser487Ser|1582/7361|1461/1536|487/511||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243235.1|Coding|12/13|c.1449A>G|p.Ser483Ser|1570/7349|1449/1524|483/507||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243232.1|Coding|15/16|c.1728A>G|p.Ser576Ser|2009/7788|1728/1803|576/600||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243233.1|Coding|15/16|c.1539A>G|p.Ser513Ser|1938/7717|1539/1614|513/537||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243231.1|Coding|17/18|c.1803A>G|p.Ser601Ser|1975/7754|1803/1878|601/625||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001083962.1|Coding|19/20|c.1941A>G|p.Ser647Ser|2553/8332|1941/2016|647/671||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243230.1|Coding|18/19|c.1920A>G|p.Ser640Ser|2014/7793|1920/1995|640/664||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_003199.2|Coding|19/20|c.1929A>G|p.Ser643Ser|2541/8320|1929/2004|643/667||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243227.1|Coding|18/19|c.1869A>G|p.Ser623Ser|2387/8166|1869/1944|623/647||,C|synonymous_variant|LOW|TCF4|TCF4|transcript|NM_001243228.1|Coding|19/20|c.1959A>G|p.Ser653Ser|2497/8276|1959/2034|653/677||;COMMON=1;SAO=0;KGPROD;VLD;RS=8766;COSMIC_ID=COSM6352805;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:2,80:82:99:2326,196,0
chr18	54291694	.	T	G	136.6	PASS	GENE=TXNL1;AC=1;AF=0.5;AN=2;BaseQRankSum=0.01;DP=10;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.66;ReadPosRankSum=-2.638;SOR=1.609;ANN=G|splice_acceptor_variant&intron_variant|HIGH|TXNL1|TXNL1|transcript|NM_004786.2|Coding|2/7|c.196-2A>C||||||,G|splice_acceptor_variant&intron_variant|HIGH|TXNL1|TXNL1|transcript|NR_024546.1|Noncoding|3/8|n.550-2A>C||||||	GT:AD:DP:GQ:PL	0/1:3,7:10:62:144,0,62
chr18	54448778	.	G	A	464.6	PASS	GENE=WDR7;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.157;DP=36;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.91;ReadPosRankSum=1.65;SOR=0.683;ANN=A|synonymous_variant|LOW|WDR7|WDR7|transcript|NM_015285.2|Coding|19/28|c.3081G>A|p.Ala1027Ala|3292/7282|3081/4473|1027/1490||,A|synonymous_variant|LOW|WDR7|WDR7|transcript|NM_052834.2|Coding|18/27|c.2982G>A|p.Ala994Ala|3193/7183|2982/4374|994/1457||;COMMON=1;SAO=0;KGPROD;VLD;RS=2302845;COSMIC_ID=COSM6352148;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:17,19:36:99:472,0,399
chr18	55221648	.	T	C	613.6	PASS	GENE=FECH;AC=1;AF=0.5;AN=2;BaseQRankSum=-3.485;DP=61;ExcessHet=3.0103;FS=2.133;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.06;ReadPosRankSum=-0.383;SOR=0.797;ANN=C|synonymous_variant|LOW|FECH|FECH|transcript|NM_001012515.2|Coding|9/11|c.939A>G|p.Pro313Pro|1056/7278|939/1290|313/429||,C|synonymous_variant|LOW|FECH|FECH|transcript|NM_000140.3|Coding|9/11|c.921A>G|p.Pro307Pro|1038/7260|921/1272|307/423||;COMMON=1;SAO=0;KGPROD;VLD;RS=536560;COSMIC_ID=COSM1130055;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:30,31:61:99:621,0,895
chr18	55226383	.	G	C	480.6	PASS	GENE=FECH;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.563;DP=47;ExcessHet=3.0103;FS=1.133;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.23;ReadPosRankSum=-0.95;SOR=0.99;ANN=C|synonymous_variant|LOW|FECH|FECH|transcript|NM_001012515.2|Coding|7/11|c.816C>G|p.Pro272Pro|933/7278|816/1290|272/429||,C|synonymous_variant|LOW|FECH|FECH|transcript|NM_000140.3|Coding|7/11|c.798C>G|p.Pro266Pro|915/7260|798/1272|266/423||;COMMON=1;SAO=0;KGPROD;VLD;RS=536765;COSMIC_ID=COSM3756165;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:25,22:47:99:488,0,732
chr18	56196451	.	C	T	534.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=17;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.41;SOR=0.804;ANN=T|synonymous_variant|LOW|ALPK2|ALPK2|transcript|NM_052947.3|Coding|6/13|c.5373G>A|p.Lys1791Lys|5587/7300|5373/6513|1791/2170||;COMMON=1;SAO=0;KGPROD;VLD;RS=7236563;COSMIC_ID=COSM1389288;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,17:17:51:548,51,0
chr18	56202768	.	C	A	1601.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=47;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.06;SOR=1.514;ANN=A|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.4651G>T|p.Ala1551Ser|4865/7300|4651/6513|1551/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809983;COSMIC_ID=COSM3756167;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,47:47:99:1615,141,0
chr18	56203074	.	G	A	633.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=19;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.32;SOR=1.022;ANN=A|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.4345C>T|p.Pro1449Ser|4559/7300|4345/6513|1449/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809982;COSMIC_ID=COSM3756168;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,19:19:57:647,57,0
chr18	56203120	.	C	T	518.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=16;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.38;SOR=0.693;ANN=T|synonymous_variant|LOW|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.4299G>A|p.Gly1433Gly|4513/7300|4299/6513|1433/2170||;COMMON=1;SAO=0;KGPROD;VLD;RS=3809981;COSMIC_ID=COSM3756169;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,16:16:48:532,48,0
chr18	56203891	.	G	T	1535.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=35;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.7;SOR=1.002;ANN=T|synonymous_variant|LOW|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.3528C>A|p.Pro1176Pro|3742/7300|3528/6513|1176/2170||;COMMON=1;SAO=0;KGPROD;VLD;RS=3809978;COSMIC_ID=COSM4827881;TISSUE=cervix;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,35:35:99:1549,105,0
chr18	56204250	.	A	C	515.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=16;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.19;SOR=0.693;ANN=C|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.3169T>G|p.Leu1057Val|3383/7300|3169/6513|1057/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809976;COSMIC_ID=COSM4999545;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,16:16:48:529,48,0
chr18	56204410	.	C	T	1477.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=35;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.23;SOR=1.148;ANN=T|synonymous_variant|LOW|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.3009G>A|p.Arg1003Arg|3223/7300|3009/6513|1003/2170||;COMMON=1;SAO=0;KGPROD;VLD;RS=55910046;COSMIC_ID=COSM1389315;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,35:35:99:1491,106,0
chr18	56204671	.	A	T	1205.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=37;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.57;SOR=0.984;ANN=T|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2748T>A|p.Asn916Lys|2962/7300|2748/6513|916/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=4940404;COSMIC_ID=COSM3756172;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,37:37:99:1219,111,0
chr18	56204747	.	G	A	955.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=24;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.29;SOR=1.27;ANN=A|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2672C>T|p.Thr891Ile|2886/7300|2672/6513|891/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3826593;COSMIC_ID=COSM4131036;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,24:24:72:969,72,0
chr18	56204932	.	T	G	964.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=29;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.24;SOR=1.255;ANN=G|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2487A>C|p.Lys829Asn|2701/7300|2487/6513|829/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809973;COSMIC_ID=COSM3756173;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,29:29:87:978,87,0
chr18	56204945	.	C	G	936.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;BaseQRankSum=1.867;DP=30;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.2;ReadPosRankSum=1.734;SOR=0.487;ANN=G|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2474G>C|p.Arg825Thr|2688/7300|2474/6513|825/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809972;COSMIC_ID=COSM3756174;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,29:30:80:950,80,0
chr18	56204977	.	C	T	1283.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=41;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.29;SOR=1.075;ANN=T|synonymous_variant|LOW|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2442G>A|p.Thr814Thr|2656/7300|2442/6513|814/2170||;COMMON=1;SAO=0;KGPROD;VLD;RS=3809971;COSMIC_ID=COSM3756175;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,41:41:99:1297,123,0
chr18	56204991	.	C	T	1292.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=43;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.05;SOR=0.941;ANN=T|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2428G>A|p.Gly810Ser|2642/7300|2428/6513|810/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3809970;COSMIC_ID=COSM3756176;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,43:43:99:1306,129,0
chr18	56205262	.	A	C	525.03	PASS	GENE=ALPK2;AC=2;AF=1;AN=2;DP=15;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.96;SOR=0.818;ANN=C|missense_variant|MODERATE|ALPK2|ALPK2|transcript|NM_052947.3|Coding|5/13|c.2157T>G|p.His719Gln|2371/7300|2157/6513|719/2170||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=12103986;COSMIC_ID=COSM3756177;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,15:15:45:539,45,0
chr18	57022754	.	T	C	1788.6	PASS	GENE=LMAN1;AC=1;AF=0.5;AN=2;BaseQRankSum=-3.242;DP=138;ExcessHet=3.0103;FS=0.622;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.96;ReadPosRankSum=-0.956;SOR=0.754;ANN=C|synonymous_variant|LOW|LMAN1|LMAN1|transcript|NM_005570.3|Coding|2/13|c.351A>G|p.Arg117Arg|383/4834|351/1533|117/510||;COMMON=1;PM;SAO=0;KGPROD;VLD;RS=1127220;PMC;COSMIC_ID=COSM5619326;TISSUE=breast;TUMOR=carcinoma -- ductal_carcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:72,66:138:99:1796,0,2155
chr18	59770033	.	C	T	899.6	PASS	GENE=PIGN;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.269;DP=50;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.99;ReadPosRankSum=0.177;SOR=0.763;ANN=T|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|20/30|c.1962G>A|p.Leu654Leu|2333/4798|1962/2796|654/931||,T|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|21/31|c.1962G>A|p.Leu654Leu|2410/4875|1962/2796|654/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=12326381;COSMIC_ID=COSM3756182;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:21,29:50:99:907,0,553
chr18	59774037	.	C	T	613.6	PASS	GENE=PIGN;AC=1;AF=0.5;AN=2;BaseQRankSum=1.664;DP=51;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.03;ReadPosRankSum=0.01;SOR=0.693;ANN=T|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|18/30|c.1752G>A|p.Leu584Leu|2123/4798|1752/2796|584/931||,T|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|19/31|c.1752G>A|p.Leu584Leu|2200/4875|1752/2796|584/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=9319997;COSMIC_ID=COSM3756183;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:31,20:51:99:621,0,925
chr18	59780424	.	A	G	715.6	PASS	GENE=PIGN;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.959;DP=58;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.34;ReadPosRankSum=0.118;SOR=0.71;ANN=G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|15/30|c.1377T>C|p.Ser459Ser|1748/4798|1377/2796|459/931||,G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|16/31|c.1377T>C|p.Ser459Ser|1825/4875|1377/2796|459/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=17714875;COSMIC_ID=COSM3756185;TISSUE=breast;TUMOR=carcinoma -- ductal_carcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:33,25:58:99:723,0,1042
chr18	59781800	.	A	G	467.6	PASS	GENE=PIGN;AC=1;AF=0.5;AN=2;BaseQRankSum=-3.648;DP=59;ExcessHet=3.0103;FS=0.992;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.93;ReadPosRankSum=-1.532;SOR=0.838;ANN=G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|14/30|c.1245T>C|p.Asp415Asp|1616/4798|1245/2796|415/931||,G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|15/31|c.1245T>C|p.Asp415Asp|1693/4875|1245/2796|415/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=13381627;COSMIC_ID=COSM3756186;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:36,23:59:99:475,0,1211
chr18	59810563	.	A	G	345.6	PASS	GENE=PIGN;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.856;DP=46;ExcessHet=3.0103;FS=1.256;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.51;ReadPosRankSum=-0.048;SOR=1.005;ANN=G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|10/30|c.939T>C|p.Asn313Asn|1310/4798|939/2796|313/931||,G|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|11/31|c.939T>C|p.Asn313Asn|1387/4875|939/2796|313/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=34227891;COSMIC_ID=COSM438287;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:32,14:46:99:353,0,1048
chr18	59814268	.	G	A	1708.03	PASS	GENE=PIGN;AC=2;AF=1;AN=2;DP=48;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.95;SOR=1.298;ANN=A|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_012327.5|Coding|8/30|c.741C>T|p.His247His|1112/4798|741/2796|247/931||,A|synonymous_variant|LOW|PIGN|PIGN|transcript|NM_176787.4|Coding|9/31|c.741C>T|p.His247His|1189/4875|741/2796|247/931||;COMMON=1;SAO=0;KGPROD;VLD;RS=9320000;COSMIC_ID=COSM3756187;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,48:48:99:1722,144,0
chr18	59814324	.	G	C	1881.03	PASS	GENE=PIGN;AC=2;AF=1;AN=2;BaseQRankSum=1.744;DP=67;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.08;ReadPosRankSum=0.052;SOR=0.248;ANN=C|missense_variant|MODERATE|PIGN|PIGN|transcript|NM_012327.5|Coding|8/30|c.685C>G|p.His229Asp|1056/4798|685/2796|229/931||,C|missense_variant|MODERATE|PIGN|PIGN|transcript|NM_176787.4|Coding|9/31|c.685C>G|p.His229Asp|1133/4875|685/2796|229/931||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=9320001;COSMIC_ID=COSM5428048;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,66:67:99:1895,187,0
chr18	59936142	.	C	T	925.6	PASS	GENE=KIAA1468;AC=1;AF=0.5;AN=2;BaseQRankSum=1.614;DP=54;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.14;ReadPosRankSum=0.097;SOR=0.645;ANN=T|synonymous_variant|LOW|KIAA1468|KIAA1468|transcript|NM_020854.3|Coding|20/29|c.2721C>T|p.Val907Val|2936/5454|2721/3651|907/1216||;COMMON=1;SAO=0;KGPROD;VLD;RS=17645999;COSMIC_ID=COSM3756189;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:22,32:54:99:933,0,538
chr18	60027241	.	C	T	113.8	PASS	GENE=TNFRSF11A;AC=2;AF=1;AN=2;DP=3;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=29.1;SOR=2.833;ANN=T|missense_variant|MODERATE|TNFRSF11A|TNFRSF11A|transcript|NM_003839.3|Coding|6/10|c.575C>T|p.Ala192Val|641/4593|575/1851|192/616||,T|missense_variant|MODERATE|TNFRSF11A|TNFRSF11A|transcript|NM_001270949.1|Coding|6/9|c.575C>T|p.Ala192Val|641/3809|575/792|192/263||,T|missense_variant|MODERATE|TNFRSF11A|TNFRSF11A|transcript|NM_001270950.1|Coding|6/8|c.575C>T|p.Ala192Val|641/3756|575/1014|192/337||,T|missense_variant|MODERATE|TNFRSF11A|TNFRSF11A|transcript|NM_001270951.1|Coding|6/7|c.575C>T|p.Ala192Val|641/3642|575/900|192/299||,T|missense_variant|MODERATE|TNFRSF11A|TNFRSF11A|transcript|NM_001278268.1|Coding|6/10|c.533C>T|p.Ala178Val|599/4551|533/1809|178/602||;COMMON=1;PM;NSM;SAO=0;KGPROD;VLD;RS=1805034;PMC;COSMIC_ID=COSM6353245;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,3:3:9:127,9,0
chr18	60231851	.	A	G	466.6	PASS	GENE=ZCCHC2;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.922;DP=21;ExcessHet=3.0103;FS=5.972;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.22;ReadPosRankSum=0.09;SOR=1.598;ANN=G|synonymous_variant|LOW|ZCCHC2|ZCCHC2|transcript|NM_017742.4|Coding|10/14|c.1734A>G|p.Gly578Gly|1734/5543|1734/3537|578/1178||;COMMON=1;SAO=0;KGPROD;VLD;RS=12956093;COSMIC_ID=COSM3756190;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:4,17:21:99:474,0,106
chr18	60241732	.	C	T	391.6	PASS	GENE=ZCCHC2;AC=1;AF=0.5;AN=2;BaseQRankSum=0.471;DP=26;ExcessHet=3.0103;FS=5.734;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.06;ReadPosRankSum=-0.567;SOR=0.674;ANN=T|synonymous_variant|LOW|ZCCHC2|ZCCHC2|transcript|NM_017742.4|Coding|13/14|c.2418C>T|p.Pro806Pro|2418/5543|2418/3537|806/1178||;COMMON=1;SAO=0;KGPROD;VLD;RS=3744926;COSMIC_ID=COSM4422674;TISSUE=kidney;TUMOR=NS -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:12,14:26:99:399,0,279
chr18	60562298	.	A	T	108.6	PASS	GENE=PHLPP1;AC=1;AF=0.5;AN=2;BaseQRankSum=1.089;DP=15;ExcessHet=3.0103;FS=5.497;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.24;ReadPosRankSum=-0.066;SOR=1.479;ANN=T|synonymous_variant|LOW|PHLPP1|PHLPP1|transcript|NM_194449.3|Coding|5/17|c.2121A>T|p.Pro707Pro|2366/6411|2121/5154|707/1717||;COMMON=1;SAO=0;KGPROD;VLD;RS=624821;COSMIC_ID=COSM4417818;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:11,4:15:99:116,0,315
chr18	60983961	.	C	T	692.03	PASS	GENE=BCL2;AC=2;AF=1;AN=2;DP=23;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.09;SOR=1.426;ANN=T|intron_variant|MODIFIER|BCL2|BCL2|transcript|NM_000633.2|Coding|2/2|c.585+1354G>A||||||;COMMON=0;SAO=0;KGPROD;RS=1541295	GT:AD:DP:GQ:PL	1/1:0,23:23:69:706,69,0
chr18	60985879	.	T	C	1059.6	PASS	GENE=BCL2;AC=1;AF=0.5;AN=2;BaseQRankSum=0.912;DP=53;ExcessHet=3.0103;FS=2.885;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.99;ReadPosRankSum=-0.566;SOR=1.337;ANN=C|synonymous_variant|LOW|BCL2|BCL2|transcript|NM_000633.2|Coding|2/3|c.21A>G|p.Thr7Thr|514/6492|21/720|7/239||,C|synonymous_variant|LOW|BCL2|BCL2|transcript|NM_000657.2|Coding|2/2|c.21A>G|p.Thr7Thr|514/1206|21/618|7/205||;COMMON=1;PM;SAO=0;KGPROD;VLD;RS=1801018;PMC;COSMIC_ID=COSM1600002;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:14,39:53:99:1067,0,238
chr18	61022791	.	C	T	1017.6	PASS	GENE=KDSR;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.65;DP=61;ExcessHet=3.0103;FS=3.93;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.68;ReadPosRankSum=0.473;SOR=0.298;ANN=T|synonymous_variant|LOW|KDSR|KDSR|transcript|NM_002035.2|Coding|4/10|c.261G>A|p.Val87Val|416/5198|261/999|87/332||;COMMON=1;SAO=0;KGPROD;VLD;RS=2003149;COSMIC_ID=COSM148435;TISSUE=stomach;TUMOR=carcinoma -- adenocarcinoma;FATHMM=PATHOGENIC;SOMATIC=Variant of unknown origin	GT:AD:DP:GQ:PL	0/1:24,37:61:99:1025,0,704
chr18	61600384	.	C	T	264.01	PASS	GENE=SERPINB10;AC=2;AF=1;AN=2;DP=9;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.33;SOR=0.892;ANN=T|missense_variant|MODERATE|SERPINB10|SERPINB10|transcript|NM_005024.1|Coding|6/7|c.736C>T|p.Arg246Cys|736/1194|736/1194|246/397||;COMMON=1;PM;NSM;SAO=0;KGPROD;VLD;RS=963075;PMC;COSMIC_ID=COSM1389512;TISSUE=soft_tissue;TUMOR=rhabdomyosarcoma -- embryonal;FATHMM=NEUTRAL;SOMATIC=Reported in another cancer sample as somatic	GT:AD:DP:GQ:PL	1/1:0,9:9:27:278,27,0
chr18	61647069	.	G	A	754.6	PASS	GENE=SERPINB8;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.166;DP=42;ExcessHet=3.0103;FS=1.302;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.97;ReadPosRankSum=1.213;SOR=0.807;ANN=A|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_002640.3|Coding|3/7|c.203G>A|p.Arg68Gln|355/3373|203/1125|68/374||,A|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_001031848.1|Coding|3/7|c.203G>A|p.Arg68Gln|355/1268|203/729|68/242||,A|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_198833.1|Coding|3/7|c.203G>A|p.Arg68Gln|372/3390|203/1125|68/374||,A|5_prime_UTR_variant|MODIFIER|SERPINB8|SERPINB8|transcript|NM_001276490.1|Coding|2/6|c.-344G>A|||||3866|;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=1944270;COSMIC_ID=COSM4000452;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:13,29:42:99:762,0,254
chr18	61654463	.	A	G	759.03	PASS	GENE=SERPINB8;AC=2;AF=1;AN=2;BaseQRankSum=0.496;DP=25;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.36;ReadPosRankSum=1.461;SOR=1.044;ANN=G|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_002640.3|Coding|7/7|c.1076A>G|p.His359Arg|1228/3373|1076/1125|359/374||,G|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_001276490.1|Coding|6/6|c.530A>G|p.His177Arg|1050/3195|530/579|177/192||,G|missense_variant|MODERATE|SERPINB8|SERPINB8|transcript|NM_198833.1|Coding|7/7|c.1076A>G|p.His359Arg|1245/3390|1076/1125|359/374||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3826616;COSMIC_ID=COSM5437808;TISSUE=oesophagus;TUMOR=carcinoma -- squamous_cell_carcinoma;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:1,24:25:46:773,46,0
chr18	67531642	.	T	C	4377.6	PASS	GENE=CD226;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.621;DP=288;ExcessHet=3.0103;FS=0.933;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.2;ReadPosRankSum=0.123;SOR=0.62;ANN=C|missense_variant|MODERATE|CD226|CD226|transcript|NM_006566.2|Coding|7/7|c.919A>G|p.Ser307Gly|1188/2637|919/1011|307/336||;COMMON=1;PM;NSM;SAO=0;KGPROD;VLD;RS=763361;PMC;COSMIC_ID=COSM1179777;TISSUE=pancreas;TUMOR=carcinoma -- ductal_carcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:109,179:288:99:4385,0,2678
chr18	67687860	.	T	C	756.6	PASS	GENE=RTTN;AC=1;AF=0.5;AN=2;BaseQRankSum=0.911;DP=43;ExcessHet=3.0103;FS=6.587;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.6;ReadPosRankSum=0.863;SOR=0.193;ANN=C|synonymous_variant|LOW|RTTN|RTTN|transcript|NM_173630.3|Coding|45/49|c.6144A>G|p.Val2048Val|6212/7093|6144/6681|2048/2226||;COMMON=1;SAO=0;KGPROD;VLD;RS=2304378;COSMIC_ID=COSM4418817;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:18,25:43:99:764,0,476
chr18	67755337	.	T	G	436.6	PASS	GENE=RTTN;AC=1;AF=0.5;AN=2;BaseQRankSum=0.106;DP=44;ExcessHet=3.0103;FS=1.186;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.92;ReadPosRankSum=0.374;SOR=0.902;ANN=G|missense_variant|MODERATE|RTTN|RTTN|transcript|NM_173630.3|Coding|31/49|c.4190A>C|p.Glu1397Ala|4258/7093|4190/6681|1397/2226||;COMMON=0;NSM;SAO=0;KGPROD;RS=72959893	GT:AD:DP:GQ:PL	0/1:27,17:44:99:444,0,765
chr18	67992279	.	G	A	279.6	PASS	GENE=SOCS6;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.446;DP=13;ExcessHet=3.0103;FS=6.368;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.51;ReadPosRankSum=1.273;SOR=0.061;ANN=A|synonymous_variant|LOW|SOCS6|SOCS6|transcript|NM_004232.3|Coding|2/2|c.375G>A|p.Thr125Thr|691/5846|375/1608|125/535||;COMMON=1;SAO=0;KGPROD;VLD;RS=2231562;COSMIC_ID=COSM6350737;TISSUE=breast;TUMOR=carcinoma -- NS;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:3,10:13:85:287,0,85
chr18	71928150	.	C	T	666.6	PASS	GENE=CYB5A;AC=1;AF=0.5;AN=2;BaseQRankSum=2.749;DP=60;ExcessHet=3.0103;FS=1.043;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.11;ReadPosRankSum=1.083;SOR=0.923;ANN=T|splice_region_variant&synonymous_variant|LOW|CYB5A|CYB5A|transcript|NM_148923.3|Coding|3/5|c.288G>A|p.Pro96Pro|429/838|288/405|96/134||,T|splice_region_variant&synonymous_variant|LOW|CYB5A|CYB5A|transcript|NM_001914.3|Coding|3/6|c.288G>A|p.Pro96Pro|429/862|288/297|96/98||,T|intron_variant|MODIFIER|CYB5A|CYB5A|transcript|NM_001190807.2|Coding|2/3|c.258+2434G>A||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=7238987;COSMIC_ID=COSM4000468;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:38,22:60:99:674,0,1056
chr18	71959075	.	G	A	1596.6	PASS	GENE=CYB5A;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.864;DP=168;ExcessHet=3.0103;FS=2.063;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.5;ReadPosRankSum=-0.858;SOR=0.907;ANN=A|synonymous_variant|LOW|CYB5A|CYB5A|transcript|NM_148923.3|Coding|1/5|c.36C>T|p.Tyr12Tyr|177/838|36/405|12/134||,A|synonymous_variant|LOW|CYB5A|CYB5A|transcript|NM_001190807.2|Coding|1/4|c.36C>T|p.Tyr12Tyr|177/808|36/375|12/124||,A|synonymous_variant|LOW|CYB5A|CYB5A|transcript|NM_001914.3|Coding|1/6|c.36C>T|p.Tyr12Tyr|177/862|36/297|12/98||;COMMON=1;NSN;SAO=0;KGPROD;VLD;RS=76198400;COSMIC_ID=COSM5654355;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=lymphoid_neoplasm -- diffuse_large_B_cell_lymphoma;FATHMM=PATHOGENIC;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:89,79:168:99:1604,0,2077
chr18	72344223	.	T	C	134.81	PASS	GENE=ZNF407;AC=1;AF=0.5;AN=2;BaseQRankSum=0.792;DP=7;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.26;ReadPosRankSum=-0.366;SOR=0.223;ANN=C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_017757.2|Coding|1/8|c.1248T>C|p.Pro416Pro|1305/8008|1248/6747|416/2248||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146190.1|Coding|1/4|c.1248T>C|p.Pro416Pro|1305/5598|1248/4983|416/1660||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146189.1|Coding|1/7|c.1248T>C|p.Pro416Pro|1305/5850|1248/5448|416/1815||;COMMON=1;SAO=0;KGPROD;VLD;RS=3794941;COSMIC_ID=COSM5426115;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:1,6:7:3:142,0,3
chr18	72345890	.	A	C	185.6	PASS	GENE=ZNF407;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.429;DP=11;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.87;ReadPosRankSum=-1.691;SOR=0.941;ANN=C|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_017757.2|Coding|1/8|c.2915A>C|p.Asn972Thr|2972/8008|2915/6747|972/2248||,C|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_001146190.1|Coding|1/4|c.2915A>C|p.Asn972Thr|2972/5598|2915/4983|972/1660||,C|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_001146189.1|Coding|1/7|c.2915A>C|p.Asn972Thr|2972/5850|2915/5448|972/1815||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=948615;COSMIC_ID=COSM3756211;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:4,7:11:99:193,0,142
chr18	72346343	.	A	G	52.6	PASS	GENE=ZNF407;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.967;DP=10;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.26;ReadPosRankSum=0;SOR=0.368;ANN=G|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_017757.2|Coding|1/8|c.3368A>G|p.Asn1123Ser|3425/8008|3368/6747|1123/2248||,G|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_001146190.1|Coding|1/4|c.3368A>G|p.Asn1123Ser|3425/5598|3368/4983|1123/1660||,G|missense_variant|MODERATE|ZNF407|ZNF407|transcript|NM_001146189.1|Coding|1/7|c.3368A>G|p.Asn1123Ser|3425/5850|3368/5448|1123/1815||	GT:AD:DP:GQ:PL	0/1:8,2:10:60:60,0,474
chr18	72346347	.	T	C	52.6	PASS	GENE=ZNF407;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.967;DP=10;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.26;ReadPosRankSum=0.728;SOR=0.368;ANN=C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_017757.2|Coding|1/8|c.3372T>C|p.Ala1124Ala|3429/8008|3372/6747|1124/2248||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146190.1|Coding|1/4|c.3372T>C|p.Ala1124Ala|3429/5598|3372/4983|1124/1660||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146189.1|Coding|1/7|c.3372T>C|p.Ala1124Ala|3429/5850|3372/5448|1124/1815||	GT:AD:DP:GQ:PL	0/1:8,2:10:60:60,0,474
chr18	72347482	.	T	C	107.6	PASS	GENE=ZNF407;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.842;DP=6;ExcessHet=3.0103;FS=3.979;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.93;ReadPosRankSum=0.431;SOR=1.414;ANN=C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_017757.2|Coding|1/8|c.4507T>C|p.Leu1503Leu|4564/8008|4507/6747|1503/2248||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146190.1|Coding|1/4|c.4507T>C|p.Leu1503Leu|4564/5598|4507/4983|1503/1660||,C|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_001146189.1|Coding|1/7|c.4507T>C|p.Leu1503Leu|4564/5850|4507/5448|1503/1815||;COMMON=1;SAO=0;KGPROD;VLD;RS=12327359;COSMIC_ID=COSM3756214;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:2,4:6:67:115,0,67
chr18	72776121	.	G	A	395.03	PASS	GENE=ZNF407;AC=2;AF=1;AN=2;DP=14;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.22;SOR=0.976;ANN=A|synonymous_variant|LOW|ZNF407|ZNF407|transcript|NM_017757.2|Coding|8/8|c.6444G>A|p.Thr2148Thr|6501/8008|6444/6747|2148/2248||;COMMON=1;SAO=0;KGPROD;VLD;RS=3744913;COSMIC_ID=COSM4131086;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,14:14:42:409,42,0
chr18	72914280	.	G	A	153.6	PASS	GENE=ZADH2;AC=1;AF=0.5;AN=2;BaseQRankSum=2.22;DP=35;ExcessHet=3.0103;FS=3.664;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.39;ReadPosRankSum=1.342;SOR=0.697;ANN=A|synonymous_variant|LOW|ZADH2|ZADH2|transcript|NM_175907.4|Coding|2/2|c.225C>T|p.Asn75Asn|493/5495|225/1134|75/377||;COMMON=1;SAO=0;KGPROD;VLD;RS=7230037;COSMIC_ID=COSM3756215;TISSUE=large_intestine;TUMOR=carcinoma -- adenocarcinoma;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:28,7:35:99:161,0,754
chr18	74521242	.	T	C	37.6	PASS	GENE=LOC100131655;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.204;DP=15;ExcessHet=3.0103;FS=3.222;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.51;ReadPosRankSum=-1.189;SOR=0.124;ANN=C|intron_variant|MODIFIER|LOC100131655|LOC100131655|transcript|NR_040024.1|Noncoding|2/2|n.368+7469A>G||||||	GT:AD:DP:GQ:PL	0/1:13,2:15:45:45,0,540
chr18	74521247	.	T	C	37.6	PASS	GENE=LOC100131655;AC=1;AF=0.5;AN=2;BaseQRankSum=-1.202;DP=15;ExcessHet=3.0103;FS=3.222;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.51;ReadPosRankSum=-1.529;SOR=0.124;ANN=C|intron_variant|MODIFIER|LOC100131655|LOC100131655|transcript|NR_040024.1|Noncoding|2/2|n.368+7464A>G||||||	GT:AD:DP:GQ:PL	0/1:13,2:15:45:45,0,540
chr18	77171061	.	T	G	63.8	PASS	GENE=NFATC1;AC=2;AF=1;AN=2;DP=3;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=21.27;SOR=1.179;ANN=G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_001278669.1|Coding|2/10|c.786T>G|p.Pro262Pro|1239/5031|786/2832|262/943||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_172390.2|Coding|2/8|c.786T>G|p.Pro262Pro|1239/2965|786/2151|262/716||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_001278670.1|Coding|2/9|c.786T>G|p.Pro262Pro|1239/4341|786/2142|262/713||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_006162.4|Coding|2/10|c.786T>G|p.Pro262Pro|1239/4724|786/2478|262/825||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_001278675.1|Coding|2/8|c.747T>G|p.Pro249Pro|865/2591|747/2112|249/703||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_001278672.1|Coding|2/9|c.747T>G|p.Pro249Pro|865/3967|747/2103|249/700||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_172387.2|Coding|2/10|c.747T>G|p.Pro249Pro|865/4657|747/2793|249/930||,G|synonymous_variant|LOW|NFATC1|NFATC1|transcript|NM_172389.2|Coding|2/10|c.747T>G|p.Pro249Pro|865/4350|747/2439|249/812||,G|intron_variant|MODIFIER|NFATC1|NFATC1|transcript|NM_172388.2|Coding|1/8|c.-191+14710T>G||||||,G|intron_variant|MODIFIER|NFATC1|NFATC1|transcript|NM_001278673.1|Coding|1/8|c.-191+10582T>G||||||;COMMON=1;SAO=0;KGPROD;VLD;RS=2230112;COSMIC_ID=COSM3756223;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,3:3:9:77,9,0
chr18	77473127	.	C	T	920.6	PASS	GENE=CTDP1;AC=1;AF=0.5;AN=2;BaseQRankSum=2.061;DP=52;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.7;ReadPosRankSum=0.271;SOR=0.667;ANN=T|missense_variant|MODERATE|CTDP1|CTDP1|transcript|NM_004715.4|Coding|7/13|c.1019C>T|p.Thr340Met|1166/3753|1019/2886|340/961||,T|missense_variant|MODERATE|CTDP1|CTDP1|transcript|NM_048368.3|Coding|7/12|c.1019C>T|p.Thr340Met|1166/3590|1019/2604|340/867||,T|missense_variant|MODERATE|CTDP1|CTDP1|transcript|NM_001202504.1|Coding|7/13|c.662C>T|p.Thr221Met|793/3380|662/2529|221/842||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=2279103;COSMIC_ID=COSM5426861;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:21,31:52:99:928,0,462
chr18	77513721	.	T	C	817.03	PASS	GENE=CTDP1;AC=2;AF=1;AN=2;DP=31;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.36;SOR=0.756;ANN=C|synonymous_variant|LOW|CTDP1|CTDP1|transcript|NM_004715.4|Coding|13/13|c.2817T>C|p.Asp939Asp|2964/3753|2817/2886|939/961||,C|synonymous_variant|LOW|CTDP1|CTDP1|transcript|NM_001202504.1|Coding|13/13|c.2460T>C|p.Asp820Asp|2591/3380|2460/2529|820/842||,C|3_prime_UTR_variant|MODIFIER|CTDP1|CTDP1|transcript|NM_048368.3|Coding|12/12|c.*50T>C|||||50|;COMMON=1;SAO=0;KGPROD;VLD;RS=626169;COSMIC_ID=COSM4131107;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	1/1:0,31:31:92:831,92,0
chr18	77662881	.	C	T	1762.6	PASS	GENE=PQLC1;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.096;DP=169;ExcessHet=3.0103;FS=2.808;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.43;ReadPosRankSum=-0.177;SOR=0.489;ANN=T|3_prime_UTR_variant|MODIFIER|PQLC1|PQLC1|transcript|NM_025078.4|Coding|6/6|c.*1095G>A|||||1095|,T|3_prime_UTR_variant|MODIFIER|PQLC1|PQLC1|transcript|NM_001146343.1|Coding|4/4|c.*1241G>A|||||1241|,T|3_prime_UTR_variant|MODIFIER|PQLC1|PQLC1|transcript|NM_001146345.1|Coding|5/5|c.*1095G>A|||||1095|;SAO=0;KGPROD;RS=115495003	GT:AD:DP:GQ:PL	0/1:92,77:169:99:1770,0,2253
chr18	77772974	.	C	A	696.02	PASS	GENE=TXNL4A-RBFA;AC=2;AF=1;AN=2;BaseQRankSum=-4.615;DP=33;ExcessHet=3.0103;FS=3.11;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=21.09;ReadPosRankSum=0.189;SOR=0.118;ANN=A|intergenic_region|MODIFIER|TXNL4A-RBFA|TXNL4A-RBFA|intergenic_region|TXNL4A-RBFA|||n.77772974C>A||||||;SAO=0;RS=62102577	GT:AD:DP:GQ:PL	1/1:2,31:33:37:710,37,0
chr18	77773006	.	A	G	1801.03	PASS	GENE=TXNL4A-RBFA;AC=2;AF=1;AN=2;DP=74;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.34;SOR=0.693;ANN=G|intergenic_region|MODIFIER|TXNL4A-RBFA|TXNL4A-RBFA|intergenic_region|TXNL4A-RBFA|||n.77773006A>G||||||;SAO=0;RS=62102578	GT:AD:DP:GQ:PL	1/1:0,74:74:99:1815,221,0
chr18	77773035	.	G	A	1800.03	PASS	GENE=TXNL4A-RBFA;AC=2;AF=1;AN=2;DP=74;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.32;SOR=0.693;ANN=A|intergenic_region|MODIFIER|TXNL4A-RBFA|TXNL4A-RBFA|intergenic_region|TXNL4A-RBFA|||n.77773035G>A||||||;SAO=0;RS=62102579	GT:AD:DP:GQ:PL	1/1:0,74:74:99:1814,221,0
chr18	77805856	.	A	C	1373.6	PASS	GENE=RBFA;AC=1;AF=0.5;AN=2;BaseQRankSum=-2.529;DP=90;ExcessHet=3.0103;FS=6.926;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.26;ReadPosRankSum=0.979;SOR=1.252;ANN=C|missense_variant|MODERATE|RBFA|RBFA|transcript|NM_024805.2|Coding|7/7|c.733A>C|p.Asn245His|883/5679|733/1032|245/343||,C|synonymous_variant|LOW|RBFA|RBFA|transcript|NM_001171967.1|Coding|6/6|c.648A>C|p.Ser216Ser|798/5594|648/729|216/242||;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3744872;COSMIC_ID=COSM5618040;TISSUE=breast;TUMOR=carcinoma -- ductal_carcinoma;FATHMM;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:42,48:90:99:1381,0,1290
chr18	77805949	.	A	C	1468.6	PASS	GENE=RBFA;AC=1;AF=0.5;AN=2;BaseQRankSum=-0.462;DP=103;ExcessHet=3.0103;FS=4.861;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=0.3;SOR=0.59;ANN=C|missense_variant|MODERATE|RBFA|RBFA|transcript|NM_024805.2|Coding|7/7|c.826A>C|p.Lys276Gln|976/5679|826/1032|276/343||,C|3_prime_UTR_variant|MODIFIER|RBFA|RBFA|transcript|NM_001171967.1|Coding|6/6|c.*12A>C|||||12|;COMMON=1;NSM;SAO=0;KGPROD;VLD;RS=3744873;COSMIC_ID=COSM4131110;TISSUE=thyroid;TUMOR=other -- neoplasm;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:52,51:103:99:1476,0,1469
chr18	77891039	.	T	A	285.6	PASS	GENE=ADNP2;AC=1;AF=0.5;AN=2;BaseQRankSum=0.837;DP=22;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.98;ReadPosRankSum=-0.927;SOR=0.446;ANN=A|synonymous_variant|LOW|ADNP2|ADNP2|transcript|NM_014913.3|Coding|3/4|c.162T>A|p.Gly54Gly|617/5387|162/3396|54/1131||;COMMON=1;SAO=0;KGPROD;VLD;RS=1064058;COSMIC_ID=COSM5428521;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:12,10:22:99:293,0,318
chr18	77894844	.	G	A	307.6	PASS	GENE=ADNP2;AC=1;AF=0.5;AN=2;BaseQRankSum=0.717;DP=16;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.23;ReadPosRankSum=-0.217;SOR=0.693;ANN=A|synonymous_variant|LOW|ADNP2|ADNP2|transcript|NM_014913.3|Coding|4/4|c.1548G>A|p.Pro516Pro|2003/5387|1548/3396|516/1131||;COMMON=1;SAO=0;KGPROD;VLD;RS=3744877;COSMIC_ID=COSM4000472;TISSUE=haematopoietic_and_lymphoid_tissue;TUMOR=haematopoietic_neoplasm -- acute_myeloid_leukaemia;FATHMM=NEUTRAL;SOMATIC=Confirmed somatic variant	GT:AD:DP:GQ:PL	0/1:6,10:16:99:315,0,152
chr18	77897719	.	C	G	2549.03	PASS	GENE=ADNP2;AC=2;AF=1;AN=2;DP=83;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.71;SOR=0.818;ANN=G|3_prime_UTR_variant|MODIFIER|ADNP2|ADNP2|transcript|NM_014913.3|Coding|4/4|c.*1027C>G|||||1027|;COMMON=0;SAO=0;KGPROD;RS=9961192	GT:AD:DP:GQ:PL	1/1:0,83:83:99:2563,248,0
